Stockwinners Market Radar for June 08, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:13 EDT Cathie Wood's ARK Investment bought 329.8K shares of UiPath today

19:09 EDT Williams-Sonoma exec Ross sells 10,400 common shares - In a regulatory filing, Williams-Sonoma brand president Ryan Ross disclosed the sale of 10,400 common shares of the company on June 6 at a price of $127.42 per share.

18:24 EDT Snowflake CEO: Our customers are not falling off a cliff - In an interview on CNBC's Mad Money, Frank Slootman said the environment for Snowflake is not rocky, but rather subdued and normal. "When I talk to customers, they are not falling off a cliff," he added. Between the current supply chain issues and inflation, what Snowflake does is "very much needed right now," ne noted.

18:11 EDT Rio Tinto calls for large-scale wind and solar power in Queensland - Rio Tinto "has called for proposals to develop large-scale wind and solar power in Central and Southern Queensland to power its aluminium assets, help meet its climate change ambitions and further encourage renewable development and industry in the region. The approach, which is through a formal market Request for Proposals, is intended to support the development of multiple new wind and solar power projects that can, in parallel with firming solutions, start supplying power to Rio Tinto's Gladstone assets through the Queensland grid by 2030."

18:07 EDT Coterra Energy exec Bell sells over 36,000 common shares - In a regulatory filing, Coterra Energy EVP of Business Development Stephen Bell disclosed the sale of 36,327 common shares of the company on June 7 at a price of $35.41 per share.

18:02 EDT PDC Energy's Kenosha Oil & Gas Development Plan in Colorado granted approval - PDC Energy announced that the Colorado Oil and Gas Conservation Commission approved the company's Kenosha Oil & Gas Development Plan - OGDP - permit application. The Kenosha OGDP encompasses 69 wells on three pads in rural Weld County, Colorado.

17:58 EDT BioMarin's treatment of primary hyperoxaluria type 1 granted orphan designation - According to a post on the FDA's website, BioMarin's treatment of primary hyperoxaluria type 1 was granted orphan designation. Reference Link

17:32 EDT Horizon Global and Continental settle patent dispute - Horizon Global subsidiary Horizon Global Americas and Continental Automotive Systems have agreed to amicably resolve their 2-year-old dispute over patent rights to their electronic trailer brake controllers. The specific terms are confidential.

17:06 EDT Uber debuts Nationwide shipping, enables 'cross-country cravings' from US cities - In a recent blog posting, Uber (UBER) announced : "Ever gotten home from vacation still craving the pizza you tasted that late night in NYC? We've been there. Ever want to surprise a friend with her hometown bagels from across the country? We're food people at Uber Eats, and we've been there too. Now with Nationwide shipping, consumers across the US can cure their cross-country cravings from beloved merchants in New York City, Miami, and Los Angeles with more cities to come soon - all with just a few taps of the Uber Eats app.Over the last few years, especially during two years of lockdowns with decreased travel, consumers have shared their desire to bring specialty food items straight to their home. But this isn't just something consumers have asked for. We've heard loud and clear merchants' desire to diversify their offerings and reach new consumers." The company added: "To place a Nationwide shipping order, open your Uber Eats app and click the "Nationwide shipping" tile. Once you've selected the merchant you want to order from, select the item(s) you'd like to purchase and add them to your cart. Confirm your order by viewing your cart and going to checkout. Review your order details and place the order! You'll receive an email with tracking information from the carrier, FedEx (FDX), soon after placing the order." Other companies in the space include DoorDash (DASH). Reference Link

17:03 EDT NewAge initiates process of evaluating potential strategic alternatives - NewAge announced that its board has initiated a process to evaluate potential strategic alternatives to maximize shareholder value. As part of the process, the board will consider a full range of strategic alternatives including available financing alternatives, a potential financial restructuring or a reorganization, merger, sale or other strategic transaction. The company has retained Houlihan Lokey as its financial advisors to assist with the strategic review process. In addition, the company has retained Lawrence Perkins and SierraConstellation Partners to serve as Chief Restructuring Officer of the company at the request of the company's board to assist management with the preparation of financial information, stakeholder communication and evaluation of cash flow generation capabilities in anticipation of the strategic review process.

16:45 EDT Five Below drops 6% to $127.72 after Q2, FY22 guidance misses estimates

16:43 EDT Greif jumps 7% to 64.99 after Q2 results beat estimates, FY22 guidance raised

16:33 EDT International Game extends partnership with SuperBook Sports into Tennessee - International Game extended its partnership with SuperBook Sports to Tennessee, where the IGT PlaySports platform is powering the SuperBook Sports mobile betting app. Tennessee marks the fourth state where IGT and SuperBook Sports have teamed up to deliver a sports betting solution. SuperBook Sports is currently leveraging IGT PlaySports technology to power retail and mobile betting in Colorado, and mobile betting in New Jersey and Arizona.

16:32 EDT Advanced Drainage exec Harvey sells 20,000 common shares - In a regulatory filing, Advanced Drainage Systems EVP of Supply Chain and Logistics Darin Harvey disclosed the sale of 20,000 common shares of the company on June 6 at a price of $112.5544 per share.

16:27 EDT Vectrus merger with Vertex recommended by proxy advisory firms ISS, Glass Lewis - Vectrus announced that independent proxy advisory firms Institutional Shareholder Services, or ISS, and Glass Lewis, recommended that Vectrus shareholders vote "for" all proposals to be considered and voted on at Vectrus's Special Meeting of Shareholders in connection with the combination with Vertex. The Special Meeting is scheduled to be held on June 15. In their reports June 3 and June 8, respectively, ISS and Glass Lewis noted: "The strategic rationale of the proposed transaction is sound, as the combined company will have increased scale and geographic, client, and contract diversity." (ISS) "The merger is expected to generate cost synergies, be accretive to earnings and free cash flow, and to provide meaningful projected tax benefits for the combined company." (ISS) "The deal would bring together two defense service providers, resulting in the creation of a larger firm that should be able to better compete for more integrated business opportunities." (Glass Lewis) "The combined company is also expected to have a more diversified revenue base across geographies, clients and contract types in supporting missions for the U.S. Department of Defense and other governmental agencies." (Glass Lewis). Under the definitive merger agreement, Vertex shareholders will own approximately 62% of the combined company on a fully diluted basis, while Vectrus shareholders will own approximately 38%. The merger is expected to close in Q3, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals and Vectrus shareholder approval.

16:24 EDT Sharps Technology sees 'near-term path to commercial manufacturing clear' - Sharps Technology published a letter to shareholders. from Robert Hayes, CEO and from Alan Blackman and Soren Christiansen on behalf of the board. Dear Fellow Shareholders: "The completion of our IPO on Nasdaq, in April, marked a major milestone in the ongoing evolution of Sharps Technology and is a key catalyst driving our transformation from an R&D focused company to revenue generating commercial operations. Moreover, the capital we raised in our IPO will enable us to scale operations in the coming quarters as we begin to meet the strong and growing demand for smart safety syringes, a market forecasted to reach $14 billion globally by 2026. As such, we believe that recent Company share prices do not reflect our true value. Our team is now working toward our next major milestone, the conclusion of our acquisition and the commencement of commercial manufacturing at our FDA/CE Mark approved facility in Hungary. We believe with the capital from our IPO we are in a position to manufacture and deliver 100 million units of our proprietary syringe products over the next 24 months. Negotiations are well underway for an onshore US based manufacturing collaboration with a major US University, which includes substantive discussions with State and Federal funding agencies. Our production targets are expected to grow significantly into 2023/24. We look forward to providing additional updates on these initiatives in the months ahead. With our near-term path to commercial manufacturing clear, our team is actively negotiating with potential distribution partners in the US, and we anticipate signing our first distributor agreement during the second half of this year. This will represent another important milestone in our transformation and should provide us with a solid foundation as we seek to rapidly expand sales and grow market share." .

16:22 EDT Cohen & Steers reports preliminary AUM $94.3B as of May 31 - A decrease of $3.7B from assets under management at April 30. The decrease was due to market depreciation of $3B, net outflows of $510M and distributions of $183M.

16:19 EDT Thomson Reuters announces new $2B share repurchase program - Thomson Reuters announced it has received approval from the Toronto Stock Exchange for the annual renewal of its normal course issuer bid. The company also announced that it plans to repurchase up to $2B of its shares under the new NCIB. Under the new NCIB, up to 24M common shares may be repurchased between June 13, 2022 and June 12, 2023.

16:14 EDT Jana Partners to sue Zendesk to set annual meeting date - JANA Partners announced that it intends to sue Zendesk for the company's failure to set a date for its 2022 annual meeting under Delaware General Corporation Law Section 211, which grants shareholders a right of action if a company fails to hold an annual meeting within 13 months of the prior year's meeting. JANA also commented on today's CNBC report that a sale process conducted by the company's board of directors is unlikely to result in a transaction, with Barry Rosenstein, Managing Partner of JANA, stating: "Zendesk's Board has inflicted significant damage on its shareholders and its incumbent directors must stop hiding from accountability. To protect against further value destruction, shareholders must be given the opportunity to vote on directors who will act in their best interests and restore desperately needed value and credibility. It is inexcusable that the Board has yet to set a date for its 2022 annual meeting. Given Zendesk's 2021 annual meeting was held on May 18, 2021, we intend to take legal action to compel the company to hold its 2022 annual meeting as promptly as possible if a meeting date is not set before the June 18 deadline. The Board must stop holding Zendesk hostage from its owners. If CNBC's reporting is accurate, Zendesk shareholders should be furious. This report of a bungled sale process-following the Board's rejection of real interest in the company in February to instead pursue the ill-conceived acquisition of Momentive, which was subsequently shunned by more than 90% of Zendesk's shareholders-would be the latest catastrophic example of the Board's inability to properly oversee management and the company. Zendesk's stock price today hit a new 52-week low, illustrating that shareholders have lost confidence in the company and further underscoring how desperately change is needed."

16:12 EDT Fluor to book $548M contract value in Q2 for Interstate 35 project in Austin, TX - Fluor "announced that it was awarded a construction contract for the Interstate 35 Capital Express South project in Austin, Texas, by the Texas Department of Transportation. Fluor will book the nearly $548M contract value in the second quarter of 2022."

16:07 EDT Opiant expands collaboration with Aptar Pharma - Opiant Pharmaceuticals (OPNT) announced a capacity investment agreement with Aptar Pharma, a provider of drug delivery systems, to expand production of Aptar's nasal Unidose device, which will be used in the production of commercial supply of OPNT003, nasal nalmefene. The agreement includes an investment by Opiant of EUR 2M (approximately $2.1M) and a commitment by Aptar to install and maintain equipment in support of increased future production of its Unidose device to meet the potential commercial demand for OPNT003, nasal nalmefene.

16:02 EDT CrossFirst Bank names Randy Rapp president - CrossFirst Bank, a subsidiary of CrossFirst Bankshares, announced the promotion of Randy Rapp to President of the Bank, effective July 1, 2022. Rapp most recently served as Chief Risk Officer and Chief Credit Officer. In his new role as President of CrossFirst Bank, Rapp will oversee the credit and risk management, sales and business development, technology and infrastructure, and operational business lines of the Bank. He will continue to report to Mike Maddox, CEO of CrossFirst Bank and President and CEO of CrossFirst Bankshares, Inc. "The promotion of Randy reflects the careful thought of our Board of Directors regarding the future leadership of our company as we position the Bank for future growth," said Maddox. "It's our strategy to recruit and retain the best talent and prepare them for success. Since joining CrossFirst in 2019, Randy has made significant contributions to our credit practices leading to improvements in the quality of our loan portfolio and financial performance. Randy has extensive experience in the financial services industry, and I am confident in his leadership abilities to accelerate our company forward."

14:25 EDT North American rail traffic fell 3.4% for the week ending June 4 - The Association of American Railroads , AAR reported U.S. rail traffic for the week ending June 4. For this week, total U.S. weekly rail traffic was 475,513 carloads and intermodal units, down 2.8% compared with the same week last year. Total carloads for the week ending June 4 were 225,274 carloads, down 1% compared with the same week in 2021, while U.S. weekly intermodal volume was 250,239 containers and trailers, down 4.4% compared to 2021. Four of the 10 carload commodity groups posted an increase compared with the same week in 2021. They included grain, up 2,515 carloads, to 23,867; motor vehicles and parts, up 1,385 carloads, to 12,518; and nonmetallic minerals, up 562 carloads, to 29,778. Commodity groups that posted decreases compared with the same week in 2021 included metallic ores and metals, down 3,222 carloads, to 20,192; miscellaneous carloads, down 1,468 carloads, to 8,037; and farm products excl. grain, and food, down 887 carloads, to 14,510. North American rail volume for the week ending June 4, 2022, on 12 reporting U.S., Canadian and Mexican railroads totaled 319,932 carloads, down 1.4% compared with the same week last year, and 331,817 intermodal units, down 5.2% compared with last year. Total combined weekly rail traffic in North America was 651,749 carloads and intermodal units, down 3.4%. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Trinity Industries (TRN), Greenbrier (GBX), FreightCar America (RAIL) and Wabtec. Reference Link

13:33 EDT Spotify CEO says strategy to work with music labels, help them be more efficient - Spotify founder and CEO Daniel Ek is speaking during the ongoing Q&A session at the company's investor day meeting.

13:18 EDT Spotify up 7% as investor day continues - Shares of Spotify are up $8.08, or 7%, to $117.51 near 1 pm ET as the company continues to host its investor day meeting. In remarks posted earlier as the event began, founder and CEO Daniel Ek stated in part: "Spotify went public in 2018 and four years into that journey, we have netted some notable accomplishments and we all know that we've weathered our share of challenges, but we've also morphed pretty dramatically as a business and I'm not sure that journey is fully understood. And frankly, we probably haven't done a very good job of explaining it... But some may also think that we're a bad business or at least a business with bad margins for the foreseeable future. And others may even think that the audio market is limited and perhaps not that significant. So today we are going to say the quiet part out loud and directly address these assumptions. To start, I believe we have a great product and importantly, our business is doing really well. But what's even more, we're really investing in building a fantastic, multi-sided platform that has all the ingredients to become one of the truly unique creative platforms in the world. And based on what we see, we are accelerating our moves to seize that opportunity in the near term. And the value creation opportunity is very high... Today, we want to share what we are building, what we call internally the Spotify Machine. And compared to 2018, I believe Spotify is in a much stronger position. We are larger and we have a much more differentiated proposition... So what happened then to our long term goals of 25-35% revenue growth and a gross margin target of 30-35%? It really comes down to this. We saw the potential to be much more than just a music company. By leveraging what we learned-and all of the technology we built-in music-and across other verticals, our ambitions became much bigger. And here's where those investments have taken us: We are now the world's largest audio streaming platform. But the prize we are going after is actually much greater and as a consequence, the total addressable market is gigantic... So while we may have traded some near term gross margin at the expense of these investments, we really believe the impact they will continue to have on the Life Time Value of users is significant. And you will hear more about this concept of Life Time Value throughout the day. This is the primary tool that I use to judge whether our strategy and investments are paying off. So we will talk a lot more about how we think about that and how we know that that drives our business. So to sum this point up: What our successes in music and podcasting has clearly demonstrated is that we have built a powerful machine and solid infrastructure that enables us to go after new verticals... We've moved from being a music discovery and playback service, to a fully-fledged platform where artists and creators can create, engage, and earn. A platform fueled by subscription, advertising and creator service models, applied to music, podcasts, audiobooks and more... And in the next couple of hours you will hear more details from our team about what this Spotify machine is capable of... And lastly, Paul Vogel, our CFO, will talk you through how all of this translates into our long term financials." Reference Link

12:33 EDT Robinhood down 4% after SEC Chairman outlines order flow payment changes

12:10 EDT Twitter testing Product Drops feature - Twitter is testing a new shopping feature, known as Product Drops, that lets brands tease products before they go on sale, and customers can sign up for reminders before the release through in-app alerts. "With Product Drops, when a merchant Tweets about an upcoming launch, you'll see a "Remind me" button at the bottom of the Tweet," the company said in a blog post. "With one tap, you can request to be reminded of the Drop. On launch day, you'll get an in-app notification in your Notifications tab 15 minutes before and at the time of the drop, so you can be among the first to shop on the merchant's website and (hopefully) beat out other shoppers. When you click on the notification, you'll see a "Shop on website" button to purchase the item on the merchant's website." For now, only shoppers in the U.S. who use Twitter in English on iOS devices will be able to see and engage with Product Drops, Twitter said, noting that it is testing the feature with "select managed partners."

12:01 EDT Boxed falls -10.6% - Boxed is down -10.6%, or -38c to $3.19.

12:00 EDT Cadre falls -14.2% - Cadre is down -14.2%, or -$3.97 to $23.97.

12:00 EDT Youdao rises 19.2% - Youdao is up 19.2%, or $1.00 to $6.20.

11:56 EDT Biogen rallies after canceling conference appearance over COVID - Shares of Biogen rallied after the company announced today that it is unable to participate in the Jefferies Healthcare Conference on Thursday, June 9, "due to considerations related to COVID." Investors often speculate that conference cancellations could portend an upcoming announcement related to an acquisition or merger. Biogen, however, attributed COVID for missing the Jefferies conference. Nonetheless, the shares are up 3% to $207.89 following the announcement.

11:49 EDT Lockheed lower as CFO talks potential for F-35 talks slipping into Q3 - While presenting at the UBS Global Industrials and Transportation Conference, Lockheed Martin CFO Jesus Malave was questioned on the Lot 15 through 17 negotiations for the F-35, to which he replied: "It's a great question. I think, though, over that 3-year period, we've learned a lot. There have been a lot of things that have happened in terms of impacts from COVID, the disruption that's caused to not only our labor, but the labor to our supply chain and being able to understand that, quantify that and put that in terms of what that means to cost and price. Same thing with what we've seen over the last 12 months of material inflation. And so the fact that it's taken as long is probably ultimately a good thing because we may not have been able to see these impacts had we closed on this before. Since we talked about this on the first quarter call, and we've been in a few conferences, I'd say the negotiating gap has closed substantially. There still is a gap, and it includes certain things like other terms. I'd say it's a handful of items that we're working diligently with the Joint Program Office to try to get closed. As I said earlier here, it's possible we can get it done by the end of the month, but it's possible it can slip out into the end of Q3... If so, we will see an impact. But again, I think both parties are motivated to try to get something done. And we're at a point now where the differences are converging... Just as a reminder, this is a percentage of completion accounting, so we would record revenue as we incur cost. But if we're under contract and don't have funding, we cannot record revenue. So we'll still keep the program on track and incur cost. But until such time we get under contract for this and get funded, we'd have to wait for that to record revenue." In morning trading, Lockheed Martin shares are down $10.50, or 2%, to $445.80.

11:16 EDT Intergrated Media Technology Ltd trading resumes

11:12 EDT BRT Apartments raises quarterly dividend 8.7% to 25c per share - BRT Apartments announced that its board of directors declared a quarterly dividend of 25c per share on the company's common stock, representing an increase of 2c per share, or 8.7%, over the prior dividend. The dividend is payable July 8 to stockholders of record on June 30.

10:27 EDT AeroClean Technologies Inc trading resumes

10:22 EDT Kroger Delivery available in South Florida - The Kroger Co. announced Kroger Delivery now serves customers in South Florida with the opening of a new spoke location in Miami. The 60,000-square-foot spoke facility, in collaboration with the Fulfillment Center in Groveland, FL, will serve as a last-mile cross-dock location that efficiently expands Kroger Delivery's ability to serve more customers. The 60,000 square-foot high-tech distribution center will bring 200 new jobs to Opa Locka and adjacent communities.

10:12 EDT Alta Fox to 'seek to maintain a dialogue' with Hasbro board - Alta Fox Capital Management, the beneficial owner of approximately 2.5% of the outstanding shares of Hasbro, issued the following statement regarding its campaign to refresh the Company's Board of Directors at the 2022 Annual Meeting of Shareholders. Connor Haley, Managing Partner of Alta Fox, commented: "We thank our fellow shareholders for their thoughtful engagement and support throughout this year's election contest. After five consecutive years of underperformance relative to the S&P 500 and an even longer period of questionable corporate governance, Alta Fox believed targeted boardroom change was necessary at the onset of a new Chief Executive Officer's tenure. We ran a campaign based on the facts: absolute and relative underperformance, numerous capital allocation blunders under long-serving incumbents, and extremely poor disclosure reflective of an insular culture. While we are disappointed in the outcome at today's Annual Meeting, we agree with Institutional Shareholders Services, Inc. that 'all shareholders likely benefited from the campaign.' Specific positives that resulted from our engagement include: Spotlighting the strength of the Wizards of the Coast business in an extensive 100-page presentation. This represents more analysis and focus on the business than Hasbro has shared with investors during its more than 20 years of ownership. Catalyzing the appointments of two gaming-focused directors, helping to fix a glaring and long-standing weakness given WOTC's ~50% contribution to overall EBITDA and its estimated ~70% of total Hasbro value based on our analysis. Spurring the Board to re-consider its Brand Blueprint strategy, as evidenced by the Company refusing to mention the strategy by name in its most recent press releases and instead purportedly undertaking a 'full assessment of our business.' Prompting improved disclosure, including of the trailing EBITDA multiple for the D&D Beyond acquisition, which the Company previously refused to provide to investors. Forcing the Board to acknowledge and confront the Company's meaningful long-term underperformance, a welcome change from its typical self-congratulatory tone. Driving multiple directors to purchase shares on the open market, whereas not a single existing director had ever purchased a single share on the open market prior to our engagement this year. Beyond these specific contributions, we also sparked a healthy debate among the frustrated Hasbro shareholder base about how to best maximize long-term shareholder value. We will seek to maintain a dialogue with the Board to ensure a culture of accountability is put in place as Chris Cocks develops and implements what will hopefully be a superior and well-articulated strategy for value creation. However, the strong shareholder response to our campaign - including support from long-term shareholders, institutional active investors and index funds - has made evident that meaningful improvements in governance and ultimately total shareholder returns are required. Hasbro's assets are too high quality to continue to underperform their potential."

10:02 EDT RippleMatch raises $45M from Goldman Sachs Asset Managment - RippleMatch announced a $45M Series B led by the Growth Equity business within Goldman Sachs Asset Management. The heavily oversubscribed round followed a year of rapid growth in which RippleMatch grew its user base 3x and drove hundreds of thousands of interviews for customers including SAP, General Mills, and Amazon.

10:00 EDT Flex LNG falls -10.0% - Flex LNG is down -10.0%, or -$3.20 to $28.82.

10:00 EDT ZIM Integrated falls -11.2% - ZIM Integrated is down -11.2%, or -$7.64 to $60.88.

10:00 EDT Annovis Bio rises 10.2% - Annovis Bio is up 10.2%, or $1.10 to $11.90.

09:56 EDT Zendesk trading resumes

09:51 EDT Zendesk trading halted, volatility trading pause

09:47 EDT Cadre falls -9.1% - Cadre is down -9.1%, or -$2.55 to $25.39.

09:47 EDT Annovis Bio rises 8.1% - Annovis Bio is up 8.1%, or 87c to $11.67.

09:47 EDT Full Truck Alliance rises 9.2% - Full Truck Alliance is up 9.2%, or 73c to $8.69.

09:40 EDT PG&E plans to reach net zero greenhouse gas emissions by 2040 - Pacific Gas and Electric Company unveiled breakthrough commitments to help reduce carbon emissions, reverse the impacts of climate change and heal the planet as part of its comprehensive Climate Strategy Report. The report outlines the company's path to become "climate positive," or going beyond net zero emissions and actively removing more greenhouse gases from the environment than it emits, by 2050. Along the way, PG&E plans to reach net zero greenhouse gas emissions by 2040, five years ahead of California's current carbon neutrality target, and has detailed clear milestones it plans to meet by 2030 in reducing emissions, adopting renewable energy, investing in clean transportation infrastructure and transitioning its natural gas system. PG&E's 2040 and 2050 commitments represent a major step in delivering upon its stand that a healthy environment and carbon-neutral energy system shall be the reality for all Californians. These commitments are also designed to ensure equity and inclusion remain at the forefront of California's energy transition by not only helping curb the devastating impacts of climate change felt by communities but also providing a pathway to a more equitable and affordable energy future. PG&E is committed to partnering with a broad spectrum of stakeholders, including customers, coworkers and community organizations, to co-create plans that will help ensure equity, and to delivering on these climate commitments in a cost-effective way, with minimal incremental impact to customer bills. PG&E recognizes that right now is a critical time for meaningful climate change action and is committed to doing its part. PG&E has laid out plans to dramatically reduce emissions attributable to the company and its customers by 2030-reductions from its operations and energy delivery equivalent to taking more than 3.2 million passenger vehicles off the road for one year. To drive this effort, the company has set targets that include: Renewable Energy Adoption: By 2030, PG&E plans to have 70% of its electric power mix consist of state-eligible renewable resources such as wind and solar. This target exceeds the state's mandate of 60% for that same year and will be met in a way that is affordable to all. Accelerate Electric Transportation: PG&E plans to be the industry's global model by fueling at least 3 million electric vehicles in its service area by 2030-leading to a cumulative reduction of at least 58 million metric tons of carbon emissions. Additionally, PG&E plans to prepare the grid to enable 2 million EVs to participate in vehicle-grid integration applications, allowing EVs to be a cornerstone of energy reliability and resilience efforts. Building Electrification and Natural Gas Transition: PG&E plans to achieve 48 million metric tons of lifecycle carbon emissions reductions by 2030 through an increased focus on energy efficiency and building electrification. To support this goal, PG&E will be evaluating all gas capital projects for electrification alternatives and will pursue electrification for projects deemed feasible and cost-effective. "Green" the Gas Supply for Hard-to-Electrify Customers: By 2030, PG&E expects that renewable natural gas will make up 15% of the gas flowing through PG&E's pipelines to core residential and commercial customers, and the company is launching a pilot to maximize readiness for hydrogen blending. PG&E also plans to reduce cumulative carbon emissions by 2.5 million metric tons by proactively converting industrial and large commercial customers unable to electrify to cleaner natural gas. Building upon the 2030 goals, PG&E will work to achieve net zero greenhouse gas emissions by 2040 by eliminating or reducing emissions and then removing remaining carbon from the atmosphere. By 2050, the company plans to be removing more greenhouse gases than it emits. As a dual commodity utility - both gas and electric - PG&E is uniquely positioned to lead this transition with customers at the center. PG&E's vision is to evolve the gas system to be an affordable, safe, and reliable net zero energy delivery platform. To make the transition, PG&E expects a diverse mix of resources to be available-from broad electrification to cleaner fuels such as renewable natural gas and hydrogen to nature-based solutions and carbon capture, storage, and utilization.

09:38 EDT Limoneira trading resumes

09:34 EDT JetBlue 'welcomes' Spirit's postponement of special meeting as 'first step' - JetBlue (JBLU) issued the following statement from CEO Robin Hayes regarding the decision by the Spirit (SAVE) board of directors: "We welcome this development as a necessary first step toward genuine negotiations between the Spirit Board and JetBlue. Spirit shareholders are clearly urging the Spirit Board to engage with us constructively and provide us with the same information previously made available to Frontier so that we can reach a consensual transaction. The improved proposal we submitted to the Spirit Board earlier this week clearly offers the most compelling value available for Spirit stockholders and we remain fully committed to acquiring Spirit. We are confident a combined JetBlue-Spirit will create a true national competitor to the dominant big four carriers that will result in lower fares and better service for customers, while offering Spirit shareholders the most attractive value creating opportunity available to them."

09:33 EDT Limoneira trading halted, volatility trading pause

09:31 EDT Loyalty Ventures trading halted, volatility trading pause

09:22 EDT Block's Afterpay, HBX partner to offer flexible spending for shoppers - Afterpay, a subsidiary of Block, announced its new partnership with HBX, Hypebeast's global e-commerce platform and retail destination, to make luxury and streetwear brands more accessible for shoppers to purchase online in four installments. The partnership will allow more Gen Z and Millennials to shop the world of contemporary fashion and lifestyle while paying over time. Zahir Khoja, General Manager of Platforms and Partnerships at Afterpay said, "We're excited to add HBX to our growing platform of designer merchants and offer curated fashion and lifestyle products that enable shoppers to use their own money to pay in four easy installments. Together, we can empower the next generation to use a payment solution that unlocks access to new and exciting products without opting into expensive credit cards that can lead them into revolving debt."

09:18 EDT Citizens Financial completes acquisition of DH Capital - Citizens Financial Group announced that it has completed its previously announced acquisition of DH Capital, a private investment banking firm serving companies in the Internet infrastructure, software and next generation IT services, and communications sectors. Headquartered in New York City with an additional office in Boulder, Colo., DH Capital has completed more than 200 merger and acquisition transactions totaling approximately $35 billion in value.

09:18 EDT Lexaria Bioscience grants license to AnodGen Bioceuticals - Lexaria Bioscience is pleased to announce the awarding of a five-year, non-exclusive DehydraTECH license from its wholly-owned subsidiary, Lexaria Pharmaceutical Corp. to AnodGen Bioceuticals of Ireland. The awarded License is valid for the manufacturing and distribution of DehydraTECH processed cannabinoid active pharmaceutical ingredient powders within Europe including the UK, Australia and New Zealand; including pharmaceutical and medical product applications for psychoactive cannabinoids and medical product applications for non-psychoactive cannabinoids. Anodgen will pay royalty fees to Lexaria for all API powders sold that utilize the DehydraTECH technology. Anodgen has the right to manufacture and sell these API powders to third party companies for their own products that are designated by a national regulator as a medical product, drug, nutraceutical, pharmaceutical or biopharmaceutical, as applicable, under its cannabinoid product license rights.

09:16 EDT East Stone, NWTN announce confidential submission of registration statement - East Stone Acquisition Corporation and ICONIQ Holding announced the confidential submission on June 7, 2022 with the U.S. Securities and Exchange Commission of a draft registration statement on Form F-4 in relation to a previously announced business combination with East Stone. Upon closing of the Business Combination, NWTN is expected to be the publicly traded entity for the combined company. Closing is conditioned upon, among other things, regulatory and shareholder approval.

09:15 EDT Udemy deploys 8,000 international courses in 13 local languages - Udemy announced Udemy Business' growth in the Asia-Pacific region. Udemy Business has expanded its global footprint with a number of enterprise customers across regions, and deployed 8,000 international courses in 13 local languages. Many courses are taught by real-world experts in their native language, removing the need for dubbing or subtitles, and as a result, localizing and enhancing the experience for both learners and instructors. The first quarter of 2022 marked Udemy Business' first full quarter of selling in South Korea through partner Woongjin ThinkBig, which resulted in almost $500K in ARR. Udemy's expansion in the Asia-Pacific region was also marked by the first-ever Udemy Business deals closed in the People's Republic of China through exclusive partner, Sanjieke. Exclusive partnerships in the region also include Benesse in Japan, who has been a partner of Udemy since 2015. "Udemy Business is continuing to grow our presence and impact across the globe, helping organizations improve employees' learning experiences. We're excited to work with organizations such as Singapore's National Library Board, Hyundai Mobis, Panasonic Connect and others across Asia Pacific," said Peter Kokkinos, Vice President & Managing Director of Udemy Business Asia Pacific. "A culture of learning is a key ingredient for a culture of success. Integrating learning into the workplace and making it a more cohesive part of day-to-day work helps improve outcomes for organizations and their teams."

09:13 EDT Cogeco's Breezeline activates residential, business customers in West Virginia - Breezeline has activated its first residential and business customers in the community of Cheat Lake in Monongalia County, West Virginia, with activations in Brookhaven and Morgantown expected later this month. Breezeline plans to activate the areas of Westover, Granville and Star City, West Virginia in early 2023. Lightning-fast Fiber-to-the-Home, FTTH, technology will be available for the very first time in many of these communities.

09:13 EDT Borqs Technologies unit HHE to play role in HECO Battery Bonus Program - Borqs Technologies announced that its Company's subsidiary, Holu Hou Energy HHE with its energy storage systems for single-family residential, multi-dwelling unit residential and commercial applications will play a role in the Battery Bonus Program introduced by Hawaiian Electric Company HECO, the Hawaiian utility. The program was announced in July 2021 for customers on Oahu and will be utilized to assist HECO in meeting the electricity need from residents during high load periods of the day. A Maui bonus program has also recently been announced.As part of the Company's ESG strategy, HHE will actively participate in Hawaii's Battery Bonus Program. For early adopters, once our customer's system is enrolled and the battery is installed and operational, HECO will issue a one-time cash payment for $5,525 and provide monthly credits totalling about $4,000 over the 10-year life of the program. This arrangement will be a great motivating factor for customers to use HHE's solar plus energy storage system. Also, HHE's system, by virtue of its high-power battery and hybrid inverter, can deliver more energy to the Battery Bonus Program than competitor solutions. For example, a customer using a HHE battery system will earn $2,000 more in total than with a battery from one the best-known solar brands. At present, HHE has enrolled 210kW of energy storage at Single-Family Residences, 57.6kW of storage in Multi-Dwelling Units, and 324kW at commercial sites. The company is targeting a total of between 8 to 13MW of energy storage through the life of the program.

09:12 EDT Sonic Automotive selected by Instabase to transform invoice processing - Instabase, the Automation Platform for Unstructured Data, announced that Sonic Automotive, a Fortune 500 Company and one of the nation's largest automotive retailers, has selected Instabase for its industry-leading automated document processing capabilities. Through this partnership, Sonic Automotive will be able to automate the processing of unstructured invoices, increasing capacity and streamlining vendor payment at lower costs across its vast network of vendors and suppliers.

09:09 EDT Ibex appoints Dan Hess as SVP, business development, healthcare - ibex announced that healthcare sales veteran Dan Hess has joined ibex as Senior Vice President, Business Development, Healthcare. Before joining ibex, Hess worked for large healthcare services delivery organizations, including Owens & Minor, Inc. and Firstsource Solutions.

09:09 EDT SRAX to host Sequire Decentralized Web Conference - SRAX announced that the Sequire Decentralized Web Conference will take place on June 23rd, 2022. Blockchain, DAOs, NFTS, and digital currencies are taking off around the world. With the user rate of cryptocurrency growing at over 100% each year, the potential is far-reaching. SRAX is bringing together a list of influential companies making history in this sector for a full day of presentations. This 1-day virtual investor event will be held via SRAX's Sequire Virtual Events platform. Nearly nine million active small-cap investors have been invited to the event, which will feature over 15 decentralized web focused companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in this space. Speakers currently include: Brock Pierce, Chairman of the Board of the Bitcoin Foundation, Scott Walker, the Co-Founder and CEO of DNA.Fund, Timothy Lewis, Founder of DEVxDAO, Jeff Dorman, Co-Founder and Chief Investment Officer of Arca, and Mrinal Manohar, the Co-Founder and CEO of CasperLabs. More keynote speakers are expected to come aboard. The presenting companies will also be able to take virtual 1:1 meetings with investors of their choice.

09:07 EDT Chevron, Cummins team on renewable natural gas engine demonstration - Chevron U.S.A., a subsidiary of Chevron Corporation (CVX), announced definitive agreements to supply fuel linked to renewable natural gas for a Walmart Inc. (WMT) demonstration of Cummins's (CMI) new 15-liter natural gas engine for heavy-duty trucks. As part of the agreements, Walmart will provide heavy-duty trucks for Cummins to integrate with the new 15-liter natural gas engine, the X15N, which runs on compressed natural gas. After taking delivery, Walmart will field-test the finished trucks at its distribution center in Fontana, California, with Chevron supplying the trucks with CNG linked to renewable natural gas.

09:05 EDT Norwegian Cruise Line releases 2021 ESG report - Norwegian Cruise Line Holdings published its 2021 Environmental, Social and Governance Report and Sustainability Accounting Standards Board index as part of the Company's global sustainability program, Sail & Sustain. Highlights from the Company's previously published 2021 Task Force on Climate-related Financial Disclosures Report are also included in the 2021 ESG Report. "We are more focused now than ever on our commitment to drive a positive impact on society and the environment through our global sustainability program, Sail & Sustain. The success of our business and our ability to deliver long-term value to our stakeholders is undeniably linked to the health of our planet, our people and the communities we visit worldwide," said Frank Del Rio, president and chief executive officer of Norwegian Cruise Line Holdings Ltd. "Our 2021 ESG Report highlights our progress and commitments on our top ESG priorities, providing critical transparency to our key stakeholders. We do not plan to stop here and we will continue to build upon our accomplishments to-date as we collectively chart a path towards a more sustainable future."

09:04 EDT Teva , Direct Relief launch new program to expand medication access - Direct Relief, the National Association of Free and Charitable Clinics, NAFC, and Teva Pharmaceuticals launched a new program to expand medication access and provide grant funding to free and charitable clinics that care for medically underserved patients suffering from depression and/or anxiety. Teva is providing free and charitable clinics with $2M in grant funding over two years and making available, on a charitable basis, a portfolio of commonly used generic medications that treat depression and anxiety. The new pilot program - initially set in Florida, New Jersey and California - aims to advance access to mental health care for uninsured populations. "Access to mental health care is critical yet distributed unevenly across the U.S.," said Thomas Tighe, CEO and President of Direct Relief. "Direct Relief is joining NAFC and Teva Pharmaceuticals in supporting community-based facilities to extend mental health care for those most in need."

09:04 EDT Verizon Response Team ready for 2022 wildfire season - The company said, "The 2022 wildfire season got off to an early start with record breaking fires that ravaged large swaths of the American Southwest beginning in April. For people who reside in the West, living with the threat of wildfire during much of the year has become part of the new normal. At Verizon, preparing for wildfires, natural disasters, extreme weather and other emergency situations is something we do all year long to keep communities and first responders connected when it matters most. Wildfire season is well underway with the hottest and driest months on the horizon, and Verizon's Response Team is ready. Experts predict another active fire season, so teams of Verizon engineers have been preparing by running emergency drills, testing fiber and cell site readiness, and ensuring recovery equipment is in place. Verizon Frontline and the Verizon Frontline Response Team also stand ready to provide first responders who will be on the front lines of potential disaster response efforts with the mission-critical communications capabilities they'll need."

09:03 EDT Rave Restaurant promotes Mike Burns to COO - Rave Restaurant announced the promotion of Mike Burns, to Executive Vice President and Chief Operating Officer effective June 27 . Burns previously served as RAVE'S Chief Operations Officer. "Mike's influence as a leader is felt throughout the company daily. Not only does he have a reputation for creating high-performing teams, he has improved our supply chain and our franchise development initiatives," says Mark Schwarz, Chairman of RAVE Restaurant Group. "Overall, he has helped us shore up operations and create efficiencies across both brands, contributing to our eight consecutive quarters of profitability."

09:00 EDT Guidewire Cloud selected by Franklin Mutual Insurance Group - Franklin Mutual Insurance Group, a P&C insurance provider for New Jersey residents and business owners, and Guidewire announced that Franklin Mutual Insurance has selected Guidewire Cloud to power its core operations and simplify its IT operations, adapt more quickly to changing market demands, and deliver more value to its policyholders. "We thank Franklin Mutual Insurance for its continued trust in Guidewire and our platform and welcome the company to the Guidewire Cloud," said John Mullen, president and chief revenue officer, Guidewire. "We are pleased by this vote of confidence in our cloud services capabilities to continue commitments to policyholders through dedication to a strong ethical culture, excellent customer service, consistency in the marketplace, and financial strength."

08:49 EDT Clever Leaves and Cantourage extend medical cannabis partnership in Germany - Clever Leaves and European medical cannabis provider Cantourage have extended their strategic partnership for the distribution of medical cannabis flowers throughout Germany. Following the introduction of Clever Leaves' IQANNA No 7 medical cannabis flowers to the German pharmaceutical market, Cantourage and Clever Leaves launched the 'IQANNA No 10'-branded Wappa cultivar. The product is cultivated in Clever Leaves' facility in Portugal, where the company operates approximately 25,000 m2 of actively producing GACP-certified greenhouses. Cantourage manufactures and distributes medical cannabis products sourced from around the world and makes them available to patients in Germany and Europe. IQANNA No 10 is the second Clever Leaves product made available to patients in Germany, with further products under the IQANNA brand to be introduced in Germany in the coming weeks.

08:46 EDT Live Oak Bancshares announces an investment in AgencyKPI - Live Oak Bancshares has announced an investment in AgencyKPI. Live Oak participated in the Series B round of financing which will support the software company's growth and add resources to continue building cloud-based software that strengthens the ability of independent insurance agencies to assess data to remain nimble and profitable."As a bank that lends to independent insurance agencies across the country, we see the extraordinary value AgencyKPI is providing," said Stephanie Mann, Live Oak's EVP of Corporate Development and Strategy. "Their business intelligence platform is driving transparency, efficiency and overall better performance for our customers. Live Oak is excited to invest in companies such as AgencyKPI that leverage next-generation technology to support business growth."The insurance industry operates on fragmented legacy systems, and AgencyKPI set out to help solve the problem with an intelligent platform that seamlessly connects the data used across networks, brokers, agencies, carriers, and wholesalers so independent insurance agents can gain operational efficiencies."We are thrilled to have a strong innovator like Live Oak Ventures participating in our Series B. Live Oak understands the insurance industry and clearly agrees with us that insurance carriers, networks and independent agencies will all benefit from a deeper understanding of their data. They believe in our vision and support our direction and we can't be more thrilled to have them among our investors," said Bobby Billman, co-founder of AgencyKPI.

08:46 EDT Omniq award $11M supply agreement from Government of Israel - OMNIQ announced that Dangot Computers Ltd, its fully owned subsidiary received an approximately $11M dollar Supply Agreement from the Government of Israel. omniQ will supply IoT equipment, consumables, and technical services to the Government's various Ministries for the next 5 years. Recurring revenue represent approximately 50% of the agreement.

08:44 EDT Scynexis submits sNDA to FDA for additional indication for BREXAFEMME in VVC - Scynexis announced the submission of a supplemental New Drug Application, sNDA, to the U.S. Food and Drug Administration FDA of an additional indication for BREXAFEMME, ibrexafungerp tablets, for the prevention of recurrent vulvovaginal candidiasis, RVVC. BREXAFEMME is a novel oral antifungal approved for the treatment of vulvovaginal candidiasis or VVC, also known as vaginal yeast infection.

08:42 EDT Phunware's PhunToken to co-sponser Consensus 2022 - PhunToken and its creator Phunware will co-sponsor Consensus 2022, which will take place in Austin, Texas, from June 9-12, 2022. The Company will also be launching the PhunToken Consensus Quest on PhunWallet, offering opportunities to win over $100K in rewards, plus a Lyte Mining PC.

08:40 EDT HeartCore Enterprises announces $3.5M repurchase program - HeartCore Enterprises, announced that its Board of Directors has authorized a share repurchase program pursuant to which the Company may repurchase up to $3.5 million of its outstanding shares of common stock. "The authorization of this share repurchase program reflects our leadership's confidence in the trajectory of the organization and our ability to generate long-term shareholder value," said CEO Sumitaka Yamamoto. "With the continuous growth of our core CMS and Digital Transformation businesses, supplemented by our latest Go IPO consulting service, we believe we are poised for a strong 2022 as we look to expand our footprint across Japan and the international markets. With the momentum we've generated so far, we strongly believe there is a disconnect between our current share price and the fair value of our common stock, based on what we believe to be HeartCore's future earnings potential."

08:39 EDT CNS Pharmaceuticals presents ongoing trial of Berubicin in GBM - CNS Pharmaceuticals presented an overview of its ongoing clinical trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme - GBM -, at the ASCO 2022 Annual Meeting. Berubicin is a novel anthracycline and the first that appears to cross the blood-brain barrier with central nervous system uptake. The induction of apoptosis and DNA damage by Berubicin was significantly higher than that of doxorubicin in all tested cancer cells, demonstrating Berubicin's greater potential potency and consistently higher cytotoxicity in GBM cell lines than Dox. In models of intracranial orthotopic gliomas, Berubicin prolongs survival when compared to temozolomide, currently the standard of care in GBM for first line therapy in combination with radiation. Berubicin had greater infiltration into intracranial glioblastoma cells compared to normal tissue, supporting the potential for improved efficacy. Based on this data, a Phase 1 dose escalation study was conducted by a prior developer in patients with recurrent primary brain tumors. Berubicin was well tolerated, with myelosuppression as dose-limiting toxicities. The company's ongoing global study is an adaptive study in adult patients with recurrent glioblastoma multiforme after failure of standard first-line therapy evaluating efficacy and safety of Berubicin. The primary endpoint is overall survival, with a projected 243 patients enrolled in a 2:1 randomization design.

08:38 EDT CPower, OmniMetrix partner for standby generator customers - OmniMetrix announced a new partnership with CPower Energy Management, which will enable OmniMetrix standby generator customers to participate in electric grid relief "demand response" programs. Demand response rewards energy users who conserve energy or switch to standby generators to help grid operators or utilities meet periodic increases in electrical power demand. Across the U.S., CPower manages more than 5.3 GW of capacity for nearly 2,000 customers at more than 12,000 sites to help the grid when and where it's needed most through its demand response solutions. CPower's demand response solutions, enabled by OmniMetrix's wireless remote generator monitoring and control, will automatically shift the power load to enrolled customers' standby generators during peak demand hours, when the grid is stressed and energy prices are high, without any action on the part of the generator owner. In addition to the peace of mind standby generators provide by ensuring reliable power during extreme weather events, consumers are now able to be compensated for allowing their standby power generators to ease peak electrical demand through demand response. The partnership will also serve as a catalyst for dealers to offer new standby generators on significantly more favorable terms to energy users; these customers will get paid for their demand response participation and the energy their generator contributes for shifting their load

08:37 EDT Evoke Pharma extends cash runway into 2Q23 - As previously disclosed, in early May, the Company utilized its "at-the-market" program to raise proceeds of approximately $7.1 million, net of commissions and fees. This cash extends the Company's cash runway into the second quarter of 2023.

08:36 EDT Sypris Electronics multi-year award for electronic warfare system upgrade - Sypris Electronics, a subsidiary of Sypris Solutions, announced that it has recently received a multi-year, follow-on award from a U.S. DOD contractor to produce and test multiple power supply modules for the upgrade of the electronic warfare suite of an important U.S. fighter aircraft program. Production is expected to transition to full-rate production beginning in 2022. Terms of the agreement were not disclosed. The power supplies to be produced by Sypris will be incorporated into a suite that will replace the functionally obsolete self-protection system of existing aircraft. The upgrade is intended to significantly improve the aircraft's capability to autonomously and automatically detect, identify and locate radio frequency threats. Updating the electronic warfare suite is critical to the aircraft, which is scheduled to be in service through 2040.

08:34 EDT Allogene Therapeutics granted RMAT designation for ALLO-501A - Allogene Therapeutics announced that the U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation to ALLO-501A in relapsed/refractory LBCL.The RMAT designation was based on the potential of ALLO-501A to address the unmet need for patients who have failed other therapies. Results from the ALPHA2 study were presented at an oral session of the American Society of Hematology annual meeting in December 2021. Data support the potential of ALLO-501A to provide a safe and durable alternative to approved autologous CAR T therapies in CAR T naive patients. ALLO-501A was associated with consistent and manageable safety with no dose limiting toxicities or graft-vs-host disease and minimal Grade 3 Immune Effector Cell-Associated Neurotoxicity Syndrome, or Grade 3 cytokine release syndrome. There were no relapses observed in LBCL CAR T naive patients who were in a complete response at six months with the longest ongoing CRs with ALLO-501A at 15+ months. Nearly all enrolled patients were able to receive therapy with the median time from enrollment to initiation of treatment of two days in ALPHA2.

08:31 EDT Orillia Soldiers' Memorial Hospital implements GE Healthcare's Encompass system - Orillia Soldiers' Memorial Hospital is implementing the first GE Healthcare Real Time Location System in Canada. Called Encompass, the equipment tracking system uses web-based and cloud-deployed technology to enable OSMH staff to locate and access the equipment they need. Healthcare assets are tagged with a Bluetooth Low Energy tracking beacon. Easier, faster access to equipment has the combined effect of improving patient experience and lowering equipment-related stresses for clinicians.

08:30 EDT Campbell Soup says cash generation 'remains strong' - Expects "continued strong demand" for brands. Remains focused on inflation mitigation.

08:29 EDT Icanic Brands announces recapitalization transaction, support agreement - Icanic Brands Company is pleased to announce that it has entered into a Restructuring Support Agreement with certain holders of its 2019 Secured Convertible Debentures, to effect a proposed recapitalization transaction, and to announce a financing of approximately US$2.0 Million arranged by insiders of the Company. The Recapitalization Transaction is the next step in the combination and integration of the Icanic and LEEF organizations following the closing of the merger of the companies on April 21, 2022. The Recapitalization Transaction will reduce the Company's outstanding indebtedness and debt service costs, improve its overall capital structure and result in an enhanced financial foundation for the Company to allow it to move forward and execute upon its business plan. Assuming Completion of the Recapitalization Transaction, the Company's pro forma outstanding indebtedness will be reduced from US$14.5 Million to approximately US$10.9 Million and its annual interest expense savings will be approximately US$110 Thousand. Pursuant to the terms of the Restructuring Support Agreement, the Recapitalization Transaction will be implemented pursuant to arrangement proceedings under the British Columbia Business Corporations Act. The Recapitalization Transaction is expected to consist of the following key elements: The 2019 Secured Convertible Debentures, which matured on June 6, 2022, will be replaced with new 2022 Secured Convertible Debentures, as further described below; The 2019 Secured Convertible Debenture holders will receive, in cash, 25% of the aggregate of the principal and interest outstanding as at June 6, 2022; The 2019 Secured Debenture holders will receive the new 2022 Secured Convertible Debentures in an amount equal to 75% of the aggregate principal and interest outstanding as of June 6, 2022; The 2022 Secured Convertible Debentures will bear interest at an annualized rate of 11% per annum and will mature 24 months from the effective date of the Recapitalization Transaction; The 2022 Secured Convertible Debentures will be convertible into a Unit of the Company at a conversion price of CAD$0.10 per Unit, with each Unit being comprised of one common share of the Company and one warrant to purchase an additional common share of the Company at a price per share of CAD$0.15 for a period of 24 months from the date of conversion; and The Company will issue additional secured convertible debentures to insiders of the Company or certain strategic investors arranged by insiders of the Company on the same terms as the 2022 Secured Convertible Debentures for up to US$2.0 million. Subject to compliance with the Restructuring Support Agreement, holders of the 2019 Secured Convertible Debenture will forbear from exercising any rights or remedies in connection with any events of default under the 2019 Secured Convertible Debenture trust indenture.

08:27 EDT Singing Machine expands distribution in Australia, New Zealand - The Singing Machine Company announced that through its existing partnership with iWorld Australia, it is expanding the number of retail doors and e-commerce platforms that will be stocking Singing Machine products for holidays 2022.

08:26 EDT Sellas shares data on 'increased survival' from study of galinpepimut-S/Opdivo - Sellas Life Sciences announced "encouraging" updated clinical data from a Phase 1 investigator-sponsored clinical trial of its lead clinical candidate, galinpepimut-S , combined with the checkpoint inhibitor nivolumab in patients with malignant pleural mesothelioma MPM who were either refractory to or relapsed after at least one line of the standard of care therapy. "Of additional importance is the fact that both trials addressed patients with bulky active disease, the setting in which other cancer vaccines have historically had very little effect. "This updated data is very encouraging, as it not only confirms our data reported in June 2021, but now reflects an increased survival benefit even though almost all additionally enrolled patients had Grade III and IV malignant mesothelioma," said Angelos Stergiou, M.D., Sc.D. h.c., President and CEO, SELLAS. "This increase in survival appears to be consistent with long term immunity-mediated antitumor effect with this immunotherapy combination and it reinforces the data we unveiled earlier this year from the Phase 1/2 clinical trial of GPS in combination with another checkpoint inhibitor, pembrolizumab, in relapsed and refractory ovarian cancer patients, in which GPS showed a superior disease control rate compared to that seen with checkpoint inhibitors alone."We believe that the results of both studies demonstrate the potential effectiveness of GPS as a combination therapy," concluded Dr. Stergiou.

08:26 EDT Pear Therapeutics presents interim results from DREAM trial - Pear Therapeutics announced interim follow-up real-world data from DREAM, a remote, decentralized trial, that showed treatment with Somryst achieved significant reductions in symptoms of insomnia, anxiety and depression severity both immediately following treatment and six months later. The results were presented as a late-breaking poster at the 36th Annual Meeting of the Associated Professional Sleep Societies, APSS, known as "SLEEP 2022," held June 4-8, 2022 in Charlotte, North Carolina. Interim data from the DREAM study, a remote, virtual, open-label, decentralized clinical trial evaluating Somryst, analyzed in mid-Q1 2022. Data cutoff for this interim analysis was January 20, 2022. Results found that patients treated with Somryst for nine weeks with digitally delivered first-line guideline recommended cognitive behavioral therapy for insomnia was associated with a significant decrease in the symptoms of insomnia severity both immediately following treatment and six months later. Additionally, scores of depression and anxiety decreased significantly both immediately following treatment and at 6-month follow-up. Specifically, interim data showed participants treated with Somryst experienced the below improvements: Insomnia Severity Index, ISI, score: The ISI score at baseline among those with severe insomnia was 23.9, at end of treatment was found to be 14.5, and at 6 months 16.7. ISI is scored on a 0-28 scale. PHQ-8: The PHQ-8 score, a 0-24 scaled measure of depression severity, at baseline among those with severe depression was 21.4, at EOT was found to be 12.7, and at 6 months 12.3. GAD-7 scale: The GAD-7 score, a 0-21 scaled measure of anxiety severity, at baseline among those with severe anxiety was 17.6, and at EOT and at 6 months was found to be 10.8.

08:24 EDT TransUnion subsidiary joins Salesforce AppExchange - Neustar, a TransUnion (TRU) company, announced it has joined the expanded Marketing Cloud Customer Data Platform ecosystem on Salesforce (CRM) AppExchange, "empowering brands to understand their customers, drive personalization at scale, and unlock new opportunities that accelerate business growth," the company said. With the Customer Data Platform and Neustar Unified Identity for Salesforce CDP app coming soon to AppExchange, customers will be able to help marketers cleanse and enrich their consumer data to power more highly targeted advertising and more personalized content across channels.

08:22 EDT Capstone Green Energy secures two EaaS contracts totaling 6 MW - Capstone Green Energy Corporation's exclusive distributor for the Mid-Atlantic and Southeastern U.S. and the Caribbean, E-Finity Distributed Generation, has secured two new 36-month Energy-as-a-Service, EaaS, contracts with a cryptocurrency mining company looking to reduce its impact on the environment. This business expansion demonstrates progress on the Company's vision to create smarter energy for a cleaner future and builds on its track record of saving its customers an estimated $698 million in annual energy savings, and reducing CO2 emissions by an estimated 1,115,100 tons of carbon, in the past three years alone. "As an EaaS provider, Capstone Green Energy is focused on growing its energy asset management business, including our industry-leading Factory Protection Plan service offering, as well as our long-term on-site energy system rental business," said Darren Jamison, President and Chief Executive Officer of Capstone Green Energy. "Our EaaS business provides a lower cost and carbon footprint for on-site energy systems in energy-intense businesses like hospitality, commercial, industrial, cannabis, and more recently, bitcoin mining," added Jamison.

08:21 EDT Fast Radius in pact with medical equipment supplier TacMed on SOF Tourniquet - Fast Radius is working with TacMed, a leading supplier of emergency medical equipment, to produce a key component used in TacMed's SOF Tourniquet. The SOF Tourniquet is a pre-hospital emergency medical device that's used by military and front-line personnel around the world to stop bleeding from potentially life-threatening limb wounds. Leveraging Fast Radius' Cloud Manufacturing Platform to rapidly scale production of a critical Tourniquet part, TacMed is able to meet increasing demand for the product in response to the conflict in Ukraine, overcoming bottlenecks within the global supply chain. "With the conflict in Ukraine, coupled with disruptions in the supply chain, we're seeing unprecedented demand for our SOF Tourniquet product," said Katie Hembree, Director of Operations at TacMed. "Our traditional supplier was unable to meet our increase in demand, which is where Fast Radius stepped in to quickly help us produce critical components of the Tourniquet. Specifically, we've benefited from Fast Radius' manufacturing expertise and network of certified suppliers, allowing us to rapidly make quality parts, meet the spike in demand, and get the end product into the hands of front-line workers around the world."

08:20 EDT Advaxis sees cash runway into 2Q24 - As of April 30, 2022, the Company had approximately $32.1 million in cash and cash equivalents.

08:19 EDT Homeserve announces acquisition of Taylor Heating - HomeServe USA announced the acquisition of Taylor Heating. One of two of founder Robert Taylor's successors, co-owner Tony DiCiacce, has been at the helm since acquiring the company in 2006. DiCiacce is taking a step back as President and settling into the new role of Senior Advisor. Co-owner Aurel Cournoyer will maintain his long-standing role as Service Manager. "Taylor Heating has been diligently serving Rochester residents for over seven decades, making it one of our longest-standing acquisitions to date," commented Deb Dulsky, Global Managing Director, HVAC at HomeServe. "They have made it clear that they match HomeServe's commitment to putting the customer at the heart of everything they do. We are thrilled to welcome them into the family, and excited to see them grow in this next chapter."

08:17 EDT Bionano Genomics publishes study using OGM to investigate inversions - Bionano Genomics announced the publication of a multi-platform study using OGM in combination with other cytogenetic technologies as a comprehensive strategy to investigate inversions that may lead to genetic disorder. This study, published in the journal Cell, analyzed inversions using various methods, including OGM. The study reported that 80% of the larger inversions that were detected were balanced and affected twice as many nucleotides overall as copy number variations-CNVs. The researchers noted that these inversions can be associated with rare genomic rearrangements found in pediatric autism, developmental delay, and epilepsy. In the study, researchers analyzed 41 unrelated human samples representing 729 inversion sites for recurrent inversion formation using complementary genomic approaches, including single-cell template strand sequencing long-read sequencing, and OGM. Using this multi-platform method, researchers found 40 recurrent inversions that encompassed 0.6% of the genome, showing that recurrent inversions can be co-localized with genomic disorder regions.

08:16 EDT Vera Bradley reducing cost structure, targeting annual savings $15M-$25M - CEO Rob Wallstrom said, "For the balance of the year, we are taking decisive actions to strengthen the enterprise and remain highly focused on our two core brands. On a Company-wide basis, we are: Meaningfully reducing our cost structure, targeting annual savings of $15 to $25 million. Continuing to evaluate and execute strategic price increases for both brands to offset rising raw material and freight costs, as appropriate. At the Vera Bradley brand, we remain confident in our core strategy, by continuing to: Innovate and build on our lifestyle merchandising strategy, with a laser focus on protecting the core, amplified by targeted marketing, by: Maximizing the travel category, which is nearly back to pre-pandemic levels. Optimizing back-to-campus opportunities, with strategic assortment enhancements. Continuing with successful product collaborations like Disney and adding new iconic partnerships including Star Wars, Coleman, and Tupperware. Expanding our footwear and home assortments this fall and holiday season. At Pura Vida, we are focused on returning the brand to long-term growth. Our newly-hired Chief Growth Officer and Pura Vida leadership team will work to build a more diverse, innovative, effective, and performance-based marketing program by bolstering our internal marketing and data analytics talent and platform. We will open three additional retail store locations, building on the success of the first store opening in San Diego in 2021. Since opening, we continue to experience a double-digit differential in our San Diego ecommerce business relative to the rest of the country, demonstrating the power a retail presence has in driving digital sales, omni-channel loyalty, and spending. Stores will play a key role in driving new customer acquisition as we continue to diversify our marketing platforms. We will build customer excitement and engagement through collaborations like Disney and Hello Kitty, partnering with key influencers, and offering themed-collections centered around key events. We are preparing for the macro environment to remain challenging through the remainder of this year and into next year. And, despite the strength in Pura Vida's store business and opportunity for new store growth, we know that it will take time to return the ecommerce business to growth as rebuilding the marketing platform and remixing the marketing program is underway. We are taking decisive actions that will further strengthen both core brands and our enterprise as a whole, not only to successfully manage through this period but position us for the future. Our teams are focused, and our cash position and balance sheet remain strong. We have successfully managed through challenging business cycles before, and I am confident we will manage through this period as well. We look forward to returning both brands to steady growth."

08:14 EDT Krispy Kreme promotes Charlesworth to Global President, COO - Krispy Kreme announced that Josh Charlesworth has been promoted to Global President and Chief Operating Officer, COO. The Company has engaged a search firm to identify Krispy Kreme's next Chief Financial Officer and Charlesworth will remain in the role until a successor is hired. Charlesworth will continue to report to Mike Tattersfield, President and Chief Executive Officer. Additionally, Andrew Skehan, President of North America, has informed the Company of his intention to leave Krispy Kreme in August to accept a Chief Executive Officer role at another organization. Andrew's current responsibilities will be assumed by several members of the Company's leadership team who have deep experience in and knowledge of the business operations.

08:13 EDT Ocuphire Pharma to present interim masked safety data for oral APX3330 - Ocuphire Pharma announced an oral presentation by key thought leader David Boyer, M.D. at the 45th Annual Macula Society Meeting, which will take place in Berlin, Germany from June 8-11, 2022. In addition, Mina Sooch, CEO and founder of Ocuphire Pharma, will participate in a virtual ophthalmology panel discussion hosted by Cantor Fitzgerald today, June 8th, at 10am EDT. "APX3330 is a novel non-invasive oral therapy, which if approved, has the potential to address the large unmet needs in diabetic retinopathy patients and other diabetes-related complications," said David Boyer, MD, Senior Partner at Retina-Vitreous Associates Medical Group, Medical Adviser to Ocuphire, and Investigator in the ZETA-1 trial. "The ongoing ZETA-1 Phase 2b trial is expected to provide valuable insights into the drug's safety and efficacy in diabetics. In February 2022, I presented early masked safety data from the trial at the Bascom Palmer Eye Institute Angiogenesis 2022 conference, which demonstrated a favorable safety and tolerability profile similar to 11 prior trials in non-ophthalmic indications. Now, with 70% of subjects through 12 weeks or more of the 24-week trial, I am excited to present new favorable and consistent safety data to an international audience at the Macula Society Meeting. Ocuphire continues to make an impression on the retinal community through numerous abstract presentations at major medical conferences."

08:11 EDT StarTek partners with Genesys for advanced experience orchestration capability - Startek announced that it has partnered with Genesys to further enhance its delivery of omnichannel solutions. As part of this partnership, Startek will combine human-centered AI and its 43,000 agents across the globe with Genesys technology to enable businesses to orchestrate flexible and scalable customer experiences. "Combining the Genesys technology with the insights it derives from the 500 million customer interactions it delivers annually, will enable Startek to expand its unified communications and collaboration solutions, deliver faster and more personalized experiences for customers and engage agents through more intuitive experiences," the company said. "By combining the power of people, technology and data insights, Startek builds empathy into every customer interaction," said Abhinandan Jain, Chief Digital Officer at Startek. "Genesys aims to make effortless experiences possible through their technology, and our shared focus on empathy as the differentiator in world-class CX makes our partnership a natural fit."

08:10 EDT Apexigen appoints William Duke as CFO - Apexigen announced the appointment of William Duke as CFO, effective immediately. Duke joins Apexigen from Kaleido, where he served as CFO and was instrumental in leading the successful completion of financings totaling $115 million.

08:08 EDT LiquidX announces strategic investment by Citi - LiquidX announced a strategic investment from Citi. The funding round was led by Broadridge, LiquidX's largest strategic investor. The investments underscore LiquidX's position as the industry's leading innovator in supply chain digitization and automation, which will deliver transformative efficiencies and value to all commercial users of the platform. LiquidX technology solutions, led by its pioneering InBlock technology platform, revolutionize the way that trade assets are managed across their entire life cycle.

08:07 EDT Greenidge Generation provides May 2022 operational update - Greenidge Generation (GREE) provided an operational update for May 2022. During May, Greenidge produced approximately 195 bitcoins (BTC). As of May 31, 2022, Greenidge had approximately 1.7 EH/s of mining capacity from approximately 20,400 miners. Approximately 25% of the capacity was located at Greenidge's facility in Spartanburg, SC which was acquired and commenced operations in December 2021.

08:07 EDT Olink, Ultima Genomics collaborate on solution for high-throughput proteomics - Olink Holding and Ultima Genomics announced that they have entered into a collaboration to enable the use of the Olink Explore high-throughput proteomics platform with Ultima's sequencing architecture. Ultima Genomics and Olink are working towards a seamless pairing of the existing Olink Explore assay and Ultima Genomics' sequencing system, and are collaborating with joint customers to enable larger-scale projects. The companies expect this will be accomplished by offering Ultima-specific library modules, along with an Olink-provided data analysis solution. Initial proof of concept data gathered by the companies shows similar performance to the existing Explore assay, signaling its potential for high-throughput proteomics customers. Additional information will be provided by Ultima during a panel discussion today, June 8th, at the Advances in Genome Biology and Technology general meeting in Orlando, Florida.

08:05 EDT Climb Channel Solutions enters partnership with Hammerspace - Climb Channel Solutions announces partnership with Hammerspace, storageless data for hybrid IT environments to efficiently provide a hybrid cloud data platform as a fully automated consumption-based resource.

08:04 EDT Mayfair Gold reports results from Fenn-Gib expansion drill program - Mayfair Gold announced further results from the Fenn-Gib expansion drill program, which is focused outside of the current conceptual pit-constrained resource. Mayfair's 100% controlled Fenn-Gib Project, located in the Timmins region of Northeast Ontario, hosts a NI43-101 Indicated Resource of 2.08M ounces with disseminated gold mineralization striking east-west on the Pipestone Fault over 1.25 kilometers and up to 300 meters wide at the west end. Mayfair Gold President and CEO Patrick Evans commented: "Mayfair's expansion drill program continues to produce excellent results from areas outside the current resource. This increases our confidence in the resource upside potential. Fenn-Gib is a large, robust gold system that has significant potential for growth. We are rapidly approaching the end of our planned 80,000m drill program and remain on track to report a resource update in Q3." Highlight drill results include: FG21-190 intersected 0.59 grams/tonne gold over 158.0m, including 1.07 g/t Au over 34.0m; FG21-216 intersected 0.64 g/t Au over 102.0m; FG21-217C intersected 0.77 g/t Au over 184.5m, including 0.98 g/t Au over 62.0m, and also including 1.31 g/t Au over 18.8m; and FG22-223 intersected 1.21 g/t Au over 112.1m, including 3.04 g/t Au over 31.5m. The latest drill results continue to intersect significant gold mineralization building on the previously reported Fenn-Gib Expansion Zone results, including: hole FG21-148, which intersected 101.0m at a grade of 0.88 g/t Au hole FG21-149, which intersected 101.9m at a grade of 0.75 g/t Au; hole FG21-150, which intersected 65.5m at a grade of 1.18 g/t Au; hole FG21-153, which intersected 233.0m at a grade of 1.05 g/t Au; FG21-206, which intersected 0.93 g/t Au over 134.2m; and hole FG21-213, which intersected 1.02 g/t Au over 92.7m.

08:04 EDT Beam Global announces continued growth in repeat orders in Q2 - Beam Global announced continued growth in repeat orders, multiple-unit orders and enterprise customer orders during the 2nd quarter of 2022, demonstrating market momentum for EV ARC sustainable EV charging systems across government and enterprise. "On the heels of a record Q1, we have a solid mix of new EV ARC orders thus far this quarter from both new and repeat customers, and the majority of these customers are placing multi-unit orders, demonstrating the increasing adoption and demand we expect to see throughout 2022," said Beam Global CEO Desmond Wheatley. "We are also seeing the return of enterprise customers with nearly 40% of new orders so far this quarter from non-government customers. I believe this combination bodes well for continued growth in 2022." Orders and deployments thus far in Q2 span 12 states, including the two new states of New Jersey and Illinois, bringing the total to 31 states in the US where EV ARC systems are deployed. EV ARC sustainable EV charging systems generate and store their own electricity, and deliver that energy to any quality brand charger the customer chooses. Because the EV ARC is off grid, it requires no permitting, no electrical work, no construction and no utility bill. Customers can continue to charge during grid outages, inclement weather and emergencies, and can offer EV charging in locations without sufficient circuitry to support EV charging.

08:02 EDT Verizon celebrates 10 years of Verizon Innovative Learning - Verizon is celebrating 10 years of its education initiative focused on addressing barriers to digital inclusion: Verizon Innovative Learning. Over the last decade, working through nonprofit partners, Verizon Innovative Learning has committed $1 billion in market value to support digital equity and inclusion within education for some of the most vulnerable populations across the country. This effort is part of Citizen Verizon, the company's responsible business plan for economic, environmental and social advancement; which is underpinned by using leading edge technology to drive social impact and create lasting change. To mark a decade of dedication to the education community, and to honor the resilience of teachers at the end of another challenging school year, Verizon is proud to support the first-ever TIME Innovative Teachers Project. Chosen by a team of editors at TIME, the list profiles 10 teachers who are changing the landscape of education in America through innovation.

08:01 EDT DavidsTea celebrates National Iced Tea Day - DAVIDsTEA is excited to announce their celebration of the upcoming National Iced Tea Day on June 10 with their "Ice Up Your Life Event." Fans are invited to enter an exciting giveaway and take advantage of special promotions that will be available each day until June 12 at all 18 DAVIDsTEA flagship stores across Canada, and online at davidstea.com.

07:50 EDT Daktronics expects volatile supply chain, labor conditions to persist - CEO Reece Kurtenbach said, "We expect dynamic and volatile supply chain and labor conditions to persist at least through the calendar year. As the environment evolves, we plan to adjust and adapt our pricing and our production schedules to best serve our customers. Our focus remains on strategically investing in new technologies and solutions, resilient supply chains, production capacity, and growing and serving our existing and new customers and markets. These strategies position us for long-term growth and increasing value for our stakeholders."

07:47 EDT Blonder Tongue Laboratories releases Clearview HEVC video transcoder - Blonder Tongue announced the release of their new Clearview HEVC advanced IP video transcoder for use by broadcasters, satellite and cable television service providers currently in the process or planning a transition to the latest MPEG HEVC/H.265 international standard for video compression. The Clearview HEVC allows those broadcasters and service providers a cost-effective path to support all end customers requiring digital television or set-top box compatibility formats and resolutions, or for use in re-broadcast architectures, headends, and central offices.

07:44 EDT Moderna announces clinical data on mRNA-1273.214 Covid booster candidate - Moderna announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 and a vaccine candidate targeting the Omicron variant of concern. A 50 microgram booster dose of mRNA-1273.214 met all pre-specified endpoints including superior neutralizing antibody response against the Omicron variant one month after administration when compared to the original mRNA-1273 vaccine.The booster dose of mRNA-1273.214 was generally well-tolerated, with side effects comparable to a booster dose of mRNA-1273 at the 50 microgram dose level. mRNA-1273.214 met all primary endpoints in the Phase 2/3 trial including neutralizing antibody response against Omicron when compared to a 50 microgram booster dose of mRNA-1273 in baseline seronegative participants. Pre-specified criteria for superiority as measured by neutralizing geometric mean titer ratio with the lower bound of the confidence interval greater than1 was met. The GMR and corresponding 97.5% confidence interval was 1.75. A booster dose of mRNA-1273.214 increased neutralizing geometric mean titers against Omicron approximately 8-fold above baseline levels. Primary endpoints of non-inferiority against ancestral SARS-CoV-2 were also met, with GMR against ancestral SAR-COV-2 of 1.22. Among seronegative participants one month after administration, the neutralizing GMT against ancestral SARS-CoV-2 for mRNA-1273.214 was 5977, compared to GMT for mRNA-1273 of 5649. The GMT against Omicron for mRNA-1273.214 was 2372, compared to GMT for mRNA-1273 of 1473. Binding antibody titers were also significantly higher against all other variants of concern for mRNA-1273.214 when compared to mRNA-1273. The mRNA-1273.214 50 undefined booster dose was well-tolerated in the 437 study participants. The safety and reactogenicity profile of the mRNA-1273.214 50 undefined booster dose was similar to that of mRNA-1273 50 undefined dose when these vaccines were administered as a second booster dose. In February 2021, Moderna announced its strategy to update booster candidates to address the ongoing evolution of the SARS-CoV-2 virus, including monovalent and bivalent candidates targeting multiple variants of concern. The Company's primary focus has been on the bivalent booster approach, which are boosters that address two viral strains simultaneously. Results from the Company's Beta-containing bivalent booster candidate, mRNA-1273.211, announced in April 2022, demonstrated superiority against Beta, Delta and Omicron variants of concern one month after administration, with continued superiority that was durable against Beta and Omicron variants of concern six months after administration. Given the significantly higher antibody titers induced by mRNA-1273.214 compared to mRNA-1273, Moderna anticipates that antibody titers induced by mRNA-1273.214 will be more durable over time against Omicron as compared to mRNA-1273. Moderna will report data from Day 91 after vaccination later in the summer. Moderna is planning to submit the interim analysis and data to regulators for review in the coming weeks.

07:42 EDT Getty Images says iStock launches VisualGPS Insights tool - iStock has launched VisualGPS Insights, an interactive tool that helps businesses make smarter decisions about their visual content. An industry first, this dynamic dashboard uses real-time iStock.com search and download data to surface global insights, easing the process of selecting imagery that resonates with consumers.

07:40 EDT Just Energy announces stay extension - Just Energy Group announced today that the Ontario Superior Court of Justice has approved the extension of the stay period under the Companies' Creditors Arrangement Act to August 19, 2022. The Stay Extension allows the Company to continue to operate in the ordinary course of business while pursuing its proposed restructuring plan, which was previously announced on May 13, 2022. The Company's motions for a Meetings Order and an Authorization Order, as previously announced on May 13, 2022, were heard by the Court on June 7, 2022. The Company will issue a further press release once the Court renders its decision with respect to such motions. As previously reported, FTI Consulting Canada is overseeing the Company's CCAA proceedings as the court-appointed Monitor.

07:38 EDT Intellia announces presentation of NTLA-2001 for ATTR amyloidosis treatment - Intellia Therapeutics announced that interim clinical data from the Phase 1 study of NTLA-2001, an investigational therapy in development for the treatment of transthyretin ATTR amyloidosis, will be shared in an oral presentation at the European Association for the Study of the Liver's International Liver Congress 2022, taking place June 22 - 26 in London. "We are pleased to be presenting longer-term, follow-up data from the first-in-human study of NTLA-2001, which is designed to potentially halt progression and reverse ATTR amyloidosis," said Intellia President and Chief Executive Officer John Leonard, M.D. "We look forward to sharing interim data we believe demonstrates the potential of our CRISPR-based investigational therapy to be a single-dose treatment that provides a deep and durable response."

07:35 EDT Neptune Wellness launches Consumer Packaged Goods focused strategic plan - Neptune Wellness Solutions announced the launch of a new Consumer Packaged Goods focused strategic plan to reduce costs, improve the company's path to profitability and enhance current shareholder value. This plan builds on the company's initial strategic review that took place in fall of 2021 and focuses on two primary actions: (1) planned accelerated divestiture of the Canadian cannabis business and (2) a realignment of focus and operational resources toward increasing the value of Neptune's consumer products business, which the company believes is showing greater potential. These actions are also intended to preserve resources towards meeting its funding requirements in the near-term while driving long-term profitability and growth. As part of the company's renewed focus on its CPG brands and Sprout Organics in particular, Neptune is delighted to announce that Sarah Tynan, current Sprout Chief Customer Officer, is promoted to CEO of Sprout, effective immediately.

07:34 EDT Roku jumps 6% to $99.08 after Insider report of internal Netflix buyout talk

07:32 EDT Better issued US Patent covering features of its digital therapeutics platform - Better Therapeutics announced that the U.S. Patent and Trade Office, USPTO, has granted their first patent, granting twenty years of exclusivity for a number of key features core to the company's digital therapeutics platform, designed to help treat cardiometabolic diseases through the delivery of digital behavioral therapy as a PDT. "Our team has been on the cutting edge of using software to help individuals change the behaviors that are the underlying causes of cardiometabolic conditions like type 2 diabetes and fatty liver disease," said Kevin Appelbaum, CEO of Better Therapeutics. "This work has resulted in a number of new and distinct inventions, and we are proud that this ingenuity has now been officially recognized by the USPTO." The new patent, U.S. Patent No. 11,355,228 granted on June 7th, 2022, is titled "SYSTEM, METHODS, AND APPARATUSES FOR MANAGING DATA FOR ARTIFICIAL INTELLIGENCE SOFTWARE AND MOBILE APPLICATIONS IN DIGITAL HEALTH THERAPEUTICS," and covers methods and apparatus for generating and monitoring a therapy regimen employing Better Therapeutics' innovative machine learning techniques. Taken together with the 510 days of patent term adjustment provided by the U.S. Patent and Trademark Office, Better Therapeutics' exclusivity will extend until at least September of 2039, absent any further patent extensions.

07:28 EDT Tonix to present data on monkeypox vaccination TNX-801 at virology meeting - Tonix Pharmaceuticals announced that Ryan Noyce, Ph.D., and David Evans, Professor, Department of Cell Biology, University of Alberta, together with scientists from Tonix presented data from a research collaboration between Tonix Pharmaceuticals and The University of Alberta in a poster presentation at the 4th Symposium of the Canadian Society for Virology held in Edmonton, Alberta, Canada on June 5 . The poster titled, "Synthetic Chimeric Horsepox Virus scHPXV Vaccination Protects Macaques from Monkeypox," describes data from animals vaccinated with TNX-8011 to protect against monkeypox. The poster presentation reports that all animals vaccinated with TNX-801 were fully protected with sterilizing immunity from a challenge with intra-tracheal monkeypox. The vaccinations with TNX-801 were well tolerated. Synthetic horsepox virus is the basis for the Company's TNX-801 vaccine in development to protect against monkeypox and smallpox and for the Company's Recombinant Pox Virus platform to protect against other pathogens, including SARS-CoV-2. "Our research work, in collaboration with Dr. Noyce and Professor Evans at The University of Alberta, shows that vaccination with TNX-801 has the ability to protect against monkeypox infection," said Seth Lederman, M.D., President and Chief Executive Officer. "Monkeypox infection of humans was rare during the time people were vaccinated to protect against smallpox. After the eradication of smallpox, vaccination with live-virus vaccinia was stopped in most of the world. Monkeypox cases have been rising in Africa for several years. Very recently a strain of monkeypox from West Africa has caused clusters of monkeypox cases in many countries outside of Africa. We believe that vaccination with live-virus vaccines like TNX-801 has the potential to control monkeypox again."

07:28 EDT Aldeyra achieves primary endpoint in Phase 3 TRANQUILITY-2 trial of reproxalap - Aldeyra Therapeutics announced the achievement of the primary endpoint in the Phase 3 TRANQUILITY-2 clinical trial of reproxalap, an investigational new drug candidate, for the treatment of dry eye disease. Reproxalap was statistically superior to vehicle for each of the two prespecified primary endpoints, Schirmer test and greater than or equal to10 mm Schirmer test responder proportions after a single day of dosing. The Schirmer test, a measure of ocular tear production, is the dry eye disease objective sign most commonly utilized for drug approval. Pending discussions with the FDA, Aldeyra intends to submit an NDA with ocular dryness symptom score, ocular redness, Schirmer test, and greater than or equal to10 mm Schirmer test responder analysis, encompassing results across five adequate and well-controlled completed clinical trials. A Type B Pre-NDA meeting is expected to be held with the FDA in the third quarter of 2022, followed by a potential NDA submission, pending enrollment in the ongoing 12-month safety trial, and results from a dry eye chamber crossover trial. Enrollment of the crossover dry eye disease trial is substantially complete, and results are expected in the third quarter of 2022. Pending the results, the crossover trial is intended to be submitted to the NDA as a supportive trial.

07:27 EDT Tiziana Life Sciences announces results in second patient with SPMS - Tiziana Life Sciences reported positive clinical results from the second patient with Secondary Progressive Multiple Sclerosis in the ongoing study as part of an expanded access program at the Brigham and Women's Hospital, Boston, MA. These results confirm the previously reported data, from the first SPMS patient after three months of treatment of the first SPMS patient. The treatment with foralumab, a fully human anti-CD3 monoclonal antibody, was well-tolerated and improved clinical and PET imaging analyses. The second patient, a young male in his 40s, was diagnosed with SPMS in 2014. Since then, the disease has been progressive, resulting in an accumulation of disability. Following completion of three months of treatment with intranasal foralumab, the patient showed improvement as measured by PET imaging, to assess inhibition of microglial activation, and by neurologic examination. Approximately 10-30% reduction in PET signal was seen across brain regions in the second SPMS patient, which is comparable to the PET changes seen in the first SPMS patient following three months of treatment with intranasal foralumab. Clinically, the Timed 25-Foot Walk test and neurologic exam were also improved. Both the first and the second patient are continuing with the treatment and are in their 13th and 4th months of treatment, respectively. The favorable safety, tolerability, and clinical responses from the first two SPMS patients were submitted to the U.S. Food and Drug Administration. The agency has now allowed Tiziana to treat an additional eight SPMS patients. Although the original dosing regimen with intranasal therapy with foralumab will remain the same, the revised dosing regimen has a provision for dose escalation up to 100 mcg as an option to improve clinical benefit.

07:25 EDT Provectus presents data on patients with mUM from liver cancer trial at ASCO - Provectus announced that updated data from the Company's initial expansion cohort of patients with uveal melanoma metastatic to the liver mUM in its cancers-of-the-liver Phase 1 trial of investigational immunocatalyst PV-10 were presented at the 2022 American Society of Clinical Oncology annual meeting, held June 3-7 in Chicago, Illinois and online.Twenty-nine percent of Stage IV M1a mUM patients achieved mCR and were alive from 12.4+ to 48.8+ months after starting PV-10 treatment. All M1a patients had hepatic metastases injected with PV-10; 50% had extrahepatic disease, which was not injected with PV-10. A portion of M1a patients underwent positron emission tomography PET-computed tomography CTPET-CT cancer imaging, which previously has not been widely recognized as an important tool for monitoring tumor response in mUM because historical treatments essentially did not produce mCRs.This ongoing single-center mUM study at MD Anderson Cancer Center MDACC in Houston, Texas has been led since inception by Sapna Patel, MD, Associate Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine at MDACC. Up to three hepatic mUM tumors can be injected per PV-10 treatment cycle. Response assessments are performed at Day 28, and then every three months. Patients with additional, injectable, visceral hepatic mUM disease may receive additional cycles of PV-10 after Day 28. Eligible patients may also receive standard of care immune checkpoint blockade either PD-1 or combination CTLA-4 + PD-1 during and after PV-10 treatment

07:23 EDT Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study - Stealth BioTherapeutics presentated new SBT-272 preclinical data demonstrating functional improvement in upper motor neurons with TDP-43 pathology, which plays a significant role in both amyotrophic lateral sclerosis - ALS - and frontotemporal dementia - FTD -. The data were presented at the Keystone Neurodegeneration Symposium in Keystone, CO held June 5-9. A Phase 1 study to evaluate the safety and tolerability of SBT-272 in healthy volunteers is underway. SBT-272 significantly improved mitochondrial structural integrity and motility in TDP-43 mutant-expressing upper motor neurons. These enhancements in mitochondrial health were associated with improved axon outgrowth, a key indicator of improved neuronal health. The effect of SBT-272 on axon outgrowth was superior to edaravone and AMX0035. Chronic in vivo administration of SBT-272 reduced upper motor neuron degeneration and neuroinflammation in the motor cortex of the prp-hTDP-43A315T-UeGFP mouse model of ALS. Together, these data support further investigation of SBT-272 as a potential treatment for ALS with TDP-43 pathology.

07:20 EDT Prime Mining announces trading on OTCQX Market - Prime Mining is pleased to report that the Company has been upgraded and qualified to trade on the OTCQX Best Market from the OTCQB Venture Market effective today under the symbol "PRMNF".

07:17 EDT MHRA, TGA, Health Canada approve KIMMTRAK to treat mUM - Immunocore Holdings announces that the United Kingdom's Medicines and Healthcare products Regulatory Agency MHRA, the Therapeutic Goods Administration TGA in Australia and Health Canada have granted marketing authorization for KIMMTRAK tebentafusp for the treatment of HLA-A02:01-positive adult patients with unresectable or metastatic uveal melanoma mUM. KIMMTRAK, a gp100 and CD3 ImmTAC novel bispecific protein, is the first bispecific T cell engager to receive regulatory approval to treat a solid tumor, and the first and only approved therapy for the treatment of unresectable or metastatic uveal melanoma. Marketing authorization by the MHRA, TGA, and Health Canada follows recent approvals from both the U.S. Food and Drug Administration and the European Commission EC. Susanna Daniels, CEO of Melanoma Focus, said: "This is a first for patients with metastatic uveal melanoma, who now have a licensed treatment available. I am thrilled at this turning point for the uveal melanoma community. We are hugely supportive of Immunocore, which has introduced a scheme to permit appropriate patients to be treated with free medicine prior to approval and public reimbursement."

07:17 EDT GXO Logistics deploys security robotics at Indiana distribution center - GXO Logistics announced that it has deployed advanced air and ground security robotics at one of its major distribution centers in Clayton, Ind., and plans to significantly increase deployment of automated security systems across other sites within the next year. This would be the largest air and ground security robotics fleet in the world. The DroneDog and DroneSentry duo, integrated with the DroneCore security platform from Asylon, Inc., are security technologies of the future, providing high-quality data and onsite activity updates that can detect potential issues in real time and simultaneously report them to the security team.

07:15 EDT Xos shares recap video of Xos Fleet Week product reveal event - Xos published a recap video of its Fleet Week product reveal event that occurred on Tuesday, May 10th. The video, at three minutes long, highlights the new 100% battery-electric MDXT and HDXT vehicles and Xosphere fleet management platform that Xos unveiled that evening.

07:14 EDT Societal CDMO announces new customer project at San Diego facility - Societal CDMO announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company's San Diego facility. The recently initiated project is focused on formulation development and sterile GMP manufacturing of a lyophilized novel cancer therapeutic for intravenous infusion. Societal has been contracted by an emerging Japan-based biopharmaceutical company to conduct this work in support of the company's ongoing clinical development of the compound as a potential treatment for solid tumors.Societal's aseptic fill/finish suite features a sterile, automated vial filling system with the capability to fill up to 2,000 presterilized vials per hour at a range of volumes. The company's lyophilization offering incorporates a novel, patented approach to uniformity and instantaneously induces nucleation via pressurization and depressurization. This equipment provides the capacity for lyophilization of approximately 9,000 10 mL vials during each 3-5 day freeze-drying cycle.

07:12 EDT Immunovant expects cash to fund requirements into 2025

07:10 EDT Gambling.com set to join Russell 3000 Index - Gambling.com Group announced it is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution, according to a preliminary list of additions posted by FTSE Russell on June 3, 2022. The inclusion on the index will take effect after the U.S. market opens on June 27, 2022. "After Gambling.com Group successfully completed its IPO last July, the inclusion of the Group's shares in the Russell Universe of Indexes is a great honor," said Charles Gillespie, Chief Executive Officer of Gambling.com Group. "Our participation in these indexes will bring the Group - the first online gambling affiliate to be publicly traded in the United States - enhanced visibility within the American equity capital markets. The inclusion is an excellent milestone for the Group, which we hope will help drive increased liquidity and investor awareness of our unique equity story."

07:09 EDT Uranium Energy receives $18M and 25 Wyoming ISR Projects - Uranium Energy, or UEC, has closed a series of transactions with Anfield Energy pursuant to which Anfield has settled $18.34M of indebtedness owing to UEC. The company received the Anfield Indebtedness through its $112M acquisition of Uranium One Americas in December 2021. The transactions also include a property swap allowing UEC to consolidate 25 additional uranium properties into its Wyoming portfolio. Subsequent to the closing of the Anfield Indebtedness, and the pending return of certain surety amounts related to the U1 Americas transaction, UEC will have over $182M of cash and liquid assets, and no debt. UEC now owns approximately 16% of Anfield on an outstanding basis. CEO Amir Adnani stated: "This week's announcement by the Biden Administration potentially marks the beginning of a new chapter in the future of the domestic U.S. nuclear fuel industry. In light of Russia's ongoing invasion of Ukraine, the Biden Administration is proposing a plan whereby the Department of Energy is asking Congress for approval and appropriations to purchase $3.5B of domestic low-enriched uranium which is comprised of uranium, conversion and enrichment services from U.S. suppliers. We look forward to working with the Department of Energy to advance U.S. national and energy security interests in domestic uranium capabilities as the U.S. transitions away from Russian supply."

07:09 EDT Mesa Air announces enhanced United Aviate partnership - Mesa Air Group announced that effective immediately Mesa Airlines pilots participating in United's Aviate career development program are now able to earn service credit, and count prior service, towards their United transition for flying across all of Mesa's operations, including American Eagle. The United Aviate program is designed to give pilots a clear path to the United Airlines flight deck while building their flight hours with Mesa. Previously, United Aviate participants could only earn service credit hours while flying aircraft operating as United Express. Mesa is pleased to communicate this opportunity to our pilots and is thankful to United for expanding the program's transition eligibility requirements. Chris Gill, Mesa Air Group MEC Chairman representing the Air Line Pilots Association, said, "We're glad Aviate has chosen to extend mainline advancement opportunities to all Mesa pilots. This represents a tremendous opportunity for our pilots, and I am confident it will also help Mesa retain and attract qualified pilots. It is our goal to help make Mesa the most attractive option for regional pilots." "We greatly appreciate the support and confidence our pilots have received from our partners at United Airlines. I believe this will make Mesa an even more attractive option for pilots entering commercial aviation. The career path of our pilots has never been more promising since I joined Mesa in 1988. I'd like to thank United and ALPA who helped make this happen," said Jonathan Ornstein, Chairman, and CEO of Mesa.

07:06 EDT Bicycle doses first patient in expansion portion of Phase I/II study of BT5528 - Bicycle Therapeutics announced the first patient has been dosed in the expansion portion of the Phase I/II study of BT5528, Bicycle's second-generation Bicycle Toxin Conjugate, BTC, targeting EphA2. "We believe EphA2 is an attractive target for cytotoxin delivery and BT5528 has the potential to overcome the significant safety concerns seen with an antibody drug conjugate approach to targeting EphA2," said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics. "We are pleased with the molecule's emerging safety profile and early signs of anti-tumor activity and look forward to providing additional data from the completed Part A portion of the Phase I/II trial next quarter."

07:05 EDT Astronics awarded contract by Southwest Airlines to provide In-Seat Power - Astronics (ATRO) announced today that it has signed an agreement with Southwest Airlines (LUV) to provide its EMPOWER Passenger In-Seat Power System for installation on 475 Boeing (BA) 737 MAX-7 and MAX-8 aircraft. This award is part of Southwest's recently announced significant cabin upgrade initiative to enhance the Customer experience. The system configuration selected by Southwest Airlines will provide 60W Type-C and 10.5W Type-A USB charging ports at every passenger seat. This will allow passengers to power and charge two devices simultaneously. Astronics will begin delivering in the fourth quarter of 2022 for retrofit installations on Southwest Airlines' existing MAX-8 fleet which will begin in early 2023. The Astronics Connectivity Systems and Certification group has been selected to provide the installation design, STC certification and installation kits for the retrofit. Deliveries to Boeing for installation on new aircraft on the production line will begin in 2023.

07:04 EDT Procter & Gamble, Microsoft announce new multiyear collaboration - The Procter & Gamble Company (PG) and Microsoft (MSFT) announced a new multiyear collaboration that will leverage the Microsoft Cloud to help create the future of digital manufacturing at P&G. The two companies will co-innovate to accelerate and expand P&G's digital manufacturing platform and leverage the Industrial Internet of Things to bring products to consumers faster, increase customer satisfaction and improve productivity to reduce costs. With Microsoft Azure as the foundation, the new collaboration marks the first time that P&G can digitize and integrate data from more than 100 manufacturing sites around the world and enhance its AI, machine learning and edge computing services for real-time visibility. This will enable P&G employees to analyze production data and leverage artificial intelligence to immediately make decisions that drive improvement and exponential impact. Accessing this level of data, at scale, is rare within the consumer goods industry. P&G selected Microsoft as its preferred cloud provider to build the future of digital manufacturing based on a four-year history of successfully working together on data and AI.

06:59 EDT West Fraser Timber increases quarterly dividend to 30c per share - West Fraser Timber Co. has declared a quarterly dividend of US$0.30 per share on the Common shares and Class B Common shares in the capital of the Company, payable on July 8, 2022 to shareholders of record on June 22, 2022. The quarterly dividend has been increased from the prior US$0.25 per share in order to distribute a substantially similar amount of capital to investors through the dividend in light of the share count reduction resulting from execution of the current normal course issuer bid as well as completion of the recent substantial issuer bid.

06:55 EDT Scorpio Tankers provides update on Q2 activities - Scorpio Tankers updated Q2 events, including the quarter to date Daily TCE Revenues. Average daily TCE revenue and duration of contracted voyages and time charters for the company's vessels thus far in Q2 were: $35K for LR2, 85% of days; $34K for the MR, 85% of days; and $35K for the Handymax, 78% of days. TCE revenue is vessel revenues less voyage expenses. As of June 6, Scorpio Tankers' outstanding principal balance on debt was $2,711.3M. Since December 31, 2021, the company has had a net reduction in debt of $452.4M, which includes the repayment of $69.7M upon the maturity of the Convertible Notes Due May 2022. The company has recently repurchased $10.8M in aggregate principal amount of its Convertible Notes due 2025 in the open market. As of June 6, the company has completed the sale of 12 vessels - 10 LR1s and two MRs - and has six vessels held for sale. The vessels held for sale are scheduled to be sold before the end of Q3.

06:52 EDT UnitedHealth announces quarterly dividend of $1.65 per share - At its regular quarterly meeting, the Board authorized payment of a cash dividend of $1.65 per share, to be paid June 28 to common stock shareholders of record as of the close of business June 20.

06:47 EDT Walker & Dunlop completes sale, financing of Houston property - Walker & Dunlop, Inc. announced that it completed the sale and structured acquisition financing for Flats at West Alabama, a 304-unit midrise apartment community located in Houston's most premium neighborhood, River Oaks.

06:43 EDT Kingsoft Cloud announces $100M share repurchase program - The company said, "Our board has authorized the company to repurchase up to $100M of our ordinary shares in the form of American depositary shares during a twelve-month period."

06:38 EDT Westwater Resources receives air permit for Kellyton graphite processing plant - Westwater Resources has received its air permit from the Alabama Department of Environmental Management. The receipt of this key permit allows Alabama Graphite Products, a subsidiary of Westwater Resources, to begin vertical construction at the Kellyton graphite processing plant and requires compliance with the Clean Air Act. The receipt of the company's air permit from ADEM is the culmination of a seven-month process that included a technical review by ADEM and a public notice and comment period. On January 31, Westwater announced it had received its NPDES permit that requires facility construction to comply with the Federal Clean Water Act and regulates disturbances and any stormwater runoff from the Kellyton plant site.

06:35 EDT Trilogy Metals announces details of 2022 Field Exploration Program - Trilogy Metals (TMQ) announced that Ambler Metals, the joint venture operating company equally owned by Trilogy and South32 Limited (SOUHY), has commenced mobilization for the upcoming exploration field program at the Upper Kobuk Mineral Projects located in northwestern Alaska. The UKMP includes the Arctic deposit, the Bornite deposit, and prospective adjoining mining claims. On May 11, 2022, the owners of Ambler Metals approved an updated summer field program resulting in an overall fiscal 2022 budget of approximately US$26.2 million for the advancement of the UKMP. The entire amount is fully funded by Ambler Metals and will consist of a minimum 10,000 meters of diamond drilling with additional meters contingent on drill performance, weather and approval of supplementary budgets. The 2022 exploration program is aligned with the strategy developed by Trilogy and South32. Priorities are advancing Arctic with additional infill drilling to further improve the confidence in the resource and the completion of a geotechnical study to further de-risk the project. Exploration outside of the Arctic deposit will focus on discovering copper-rich satellite deposits near Arctic, and in the Cosmos Hills and the Ambler Lowlands along strike from Bornite. Preparations are underway with the mobilization of crews and equipment in progress, and drilling is expected to commence in early June. Major Drilling was awarded a multi-year contract to provide three diamond drill rigs with crews. Major has experience at the UKMP from drill campaigns in 2017, 2018 and 2019. The drill program is helicopter-supported and is based out of Ambler Metals' expanded 90-person camp at Bornite.

06:34 EDT MediciNova's MN-166 shows positive top-line Phase 2 results in COVID-19 - MediciNova announced positive top-line results from MediciNova's Phase 2 clinical trial of MN-166 - ibudilast - in hospitalized COVID-19 patients at risk for developing acute respiratory distress syndrome, or ARDS. MN-166 demonstrated large improvements compared to placebo for all four clinical endpoints analyzed. The trial achieved statistical significance for one of the co-primary endpoints, the proportion of subjects free of respiratory failure. The trial also achieved statistical significance for the proportion of subjects discharged from the hospital. Co-primary endpoint of the proportion of subjects free from respiratory failure at Day 7: 71% of subjects in the MN-166 group and 35% of subjects in the placebo group. Co-primary endpoint of clinical status at Day 7: 71% of subjects in the MN-166 group and 47% in the placebo group. Proportion of subjects discharged from the hospital at Day 7: 65% of subjects in the MN-166 group and 29% in the placebo group. Subjects with worsening of clinical status at Day 7: 0% of subjects in the MN-166 group, 24% in the placebo group. There were two deaths in the placebo group and no deaths in the MN-166 (ibudilast) group. There were no serious adverse events related to MN-166. The company plans to discuss the results of this study with the FDA and get their feedback to determine next steps.

06:32 EDT Thor Industries expects retail demand for 2022 'will be strong' - "The RV industry's calendar 2022 retail selling season has been impacted by the current macroeconomic conditions faced by consumers, and while North American industry retail towable demand is anticipated to be lower than the historically high levels of recent quarters, it remains robust as enthusiasm for the RV lifestyle continues to grow. Motorized industry retail demand continues to outpace the industry's ability to produce given the limitations on chassis supply. Industry retail registrations in the first calendar quarter of 2022, while below the record levels of 2021, exceeded both 2020 and 2019 registrations in both North America and Germany. We believe retail demand for the remainder of our Fiscal Year 2022 and the beginning of Fiscal 2023 will be strong, barring additional macroeconomic impacts, and we expect calendar year 2022 North American RV industry retail sales of between 460,000 and 480,000 units, which would represent one of the best years of North American RV retail sales on record," continued Woelfer. "Based on the recent moderation of North American retail demand, the RV Industry Association recently reduced its North American wholesale forecast for calendar year 2022 shipments to be between 537,800 and 561,900 units with a most likely total of 549,900 units. We agree with the revised lower end of the wholesale RVIA's forecast, and we believe it is in alignment with our forecasted RV industry retail sales as a number of the wholesale units shipped so far this year were used to restock dealer towable inventories to more normalized levels. Looking ahead to the second half of the calendar year, we expect RV Industry wholesale shipments and retail RV sales to be closer to one-to-one parity, as we work to manage wholesale production to align with retail demand. As the world's leading RV manufacturer, we recognize the importance of maintaining production discipline as we strive to fulfill dealer orders that are in balance with retail sales forecasts. Our production discipline is greatly valued among our dealer partners as we work to protect the long-term interests of our customers and the industry," concluded Woelfer. "As always, we remain focused on driving growth, profitability and long-term value for all of our stakeholders. We are currently implementing many strategic and innovative initiatives to expand our industry leadership position in fiscal year 2023 and beyond. We look forward to sharing our long-term vision, priorities and financial targets with you at our Investor Day in late June," added Martin.

06:18 EDT RosCan Gold outlines potential resource growth beyond first MRE - Roscan Gold Corporation is pleased to present its ongoing exploration activities and potential resource growth beyond the recently announced first mineral resource estimate. The ongoing exploration activities have been focused on two key areas: 1) The expansion of the maiden resource within the MRE areas, which it is estimated to currently comprise a potential additional resource in the range of 8Mt at 1.0 g/t Au to 30Mt at 0.8 g/t Au and; 2) outside the MRE, which has seen substantial positive exploration results but has not yet been captured in the reported MRE. Key Highlights: 17,890 meters out of the 20,000 m ongoing drilling program have been completed beyond the drilling data included in the MRE. 8,050 m are infill drilling in the resources areas focuses under the 1,500 USD pit shell and 5,500 m of step out drilling program in the vicinity of the resource zones. Drilling prioritization to favor areas of immediate upside potential such as the Exploration Target areas at Mankouke South, Kabaya and Kandiole KN1 resource areas, including the oxide and sulphide mineralization, their satellites and extensions. Additional areas of prioritization outside the MRE area includes the discoveries at Disse and Walia, and Mankouke West along with the strong potential of Bantanko East and Segondo West and several other targets in in the Siribaya-Mankouke-Seko structural corridor. Further potential to increase the resource estimates with LeachWELL assay process: Only 18% of current drilling has now been assayed by LeachWELL which thus far has shown substantial improvements in areas tested; increasing between 10% and 40 %. Roscan plans to expand the use of LeachWELL on its existing resource base and to use it extensively for all future drilling. Nana Sangmuah, President & CEO, stated, "We are extremely excited by our MRE that suggests a stand-alone potential operation with over a million ounces delineated in the indicated category at a very conservative gold price of $1500/oz. We are even more excited by the growth potential to be unlocked with over 5,500 meters of drilling completed in our expanded resource target areas and newer discoveries like Disse. Our goal is to continue to explore and to convert these potential growth areas into additional ounces in constrained pits in the coming months."

06:12 EDT RosCan Gold announces interim resources at Kandiole Project in Mali - Roscan Gold is pleased to announce its initial, pit-constrained, interim NI 43-101 compliant Mineral Resources reported at a gold price of only 1,500 USD per oz, of 27.4 million tonnes grading 1.2 g/t Au totaling 1.02 million ounces of gold in the Indicated Category and 5.2 million tonnes grading 1.2 g/t Au totaling 198,000 ounces of gold in the Inferred category at its Kandiole project in Mali. Roscan's maiden pit constrained Mineral Resource includes gold mineralization from six mineral deposits: Mankouke South, Mankouke Central, Kandiole1, Kandiole 2 and 4, Kabaya and Moussala. The discovery areas of Disse, Walia and Mankouke West were not included in the maiden resource due to lack of sufficient drilling to date but will be areas of upside for future exploration. The cutoff date for data used in the resource estimate was March 25 th 2022. Since March 25 th , Roscan has continued its drilling campaign to infill and extend the saprolite resource area and to follow up on the deeper mineralization at the Mankouke South and Kandiole targets. Drilling results have encountered plunging zones of mineralization that remain open, which are currently being drilled and assayed. Key Highlights: Robust initial Mineral Resource reported at a 0.3 g/t Au and 0.42 cut-off grade and $1500 per ounce gold price; Indicated Mineral Resource of 27.4mt at 1.2 g/t Au, and Inferred Mineral Resource of 5.2mt at 1.2 g/t Au; Resource calculation sensitivity at a 0.5g/t Au cut-off and $1500 per ounce gold price; Indicated Mineral Resource of 20.0mt at 1.5 g/t Au, and Inferred Mineral Resource of 3.8mt at 1.4 g/t Au; Preliminary pit shells at Mankouke South indicate a low strip-ratio resource that is mostly oxide, with a robust starter pit of between 5.3 million tonnes at 2.2 g/t and 4.5 million tonnes at 2.6 g/t; Resource model sensitivities at various gold prices highlight low strip ratios from pit shells ranging from 2.4:1 to 2:7:1; Mineral resource with 84% captured in the indicated category and minimal sensitivity to lower gold prices. Further potential to improve resource estimates with LeachWELL assay process. Only 18% of current drilling has now been assayed by LeachWELL which thus far has shown substantial improvements with tested area's lower-grades increasing between 10% and 40 %. Roscan plans to expand the use of LeachWELL on its existing resource base and to use it extensively for all future drilling. Further Exploration Upside; Significant potential to increase the size of the MR with both the currently ongoing and future drilling programs. Identified mineralization under continued exploration include the follow up on the oxide and sulphide mineralization at Mankouke South, Kabaya and Kandiole KN1 resource areas, including their satellites and extensions. Nana Sangmuah, President & CEO, stated , "This mineral resource suggests a stand-alone project status for the Kandiole Gold Project. The good metallurgical recoveries, high-grade starter pit, low strip ratios, and the high-quality resource with 84% included in the indicated resource category and 72% within saprolite, points to a potential high-margin LOM operation. Importantly, this initial resource is just the beginning for the overall project potential, the mineral resource remains open to further growth with the pending results from our incremental drilling, which remains ongoing. In addition, there are 3 advanced targets and discoveries not yet captured to be included in subsequent updates, such as demonstrated by the drilling success at Walia, Disse and Kandiole North extension. Management intends to commence in short order environmental studies to facilitate the permitting and further de-risking project development. We are encouraged by the ultimate scale potential at the Kandiole Project which we believe has significant upside and clearly positions Roscan amongst the few junior resource companies that can transition from early exploration to a significant mining operation."

06:06 EDT Oppenheimer appoints John Putrino as co-head, real estate investment banking - Oppenheimer & Co. announced the continued expansion of its Financial Institutions team with the appointment of John Putrino as Co-Head of Real Estate Investment Banking and Head of Lodging & Leisure Investment Banking, working alongside Cliff Booth, who previously joined as Head of Specialty Finance and Co-Head of Real Estate Investment Banking. Putrino will report to Gilbert Dychiao, Head of Financial Institutions at Oppenheimer. Putrino was most recently Head of Lodging & Leisure Investment Banking and Managing Director at Janney Montgomery Scott.

06:03 EDT Multiverse raises $220M in Series D funding round - Multiverse has closed a $220 million Series D funding round at a post-money valuation of $1.7 billion, doubling its valuation from eight months ago. The latest round was co-led by StepStone Group, and returning investors Lightspeed Venture Partners and General Catalyst. The funding will be used to accelerate US expansion and broaden the range of learning programs, creating more routes to career progression for apprentices and helping organizations close digital skills gaps across their workforce. Founders Circle Capital and existing investors Audacious Ventures, BOND, D1 Capital Partners, GV and Index Ventures also participated in the round, bringing total funding to over $400 million.

05:53 EDT Aurora Mobile launches Overseas Messaging Cloud Solution - Aurora Mobile announced it has recently launched its Overseas Messaging Cloud Solution to serve Chinese enterprises' international expansion as well as overseas markets. By integrating multiple messaging products such as JPush, SMS, email, JG UMS and other messaging products, the Solution focuses on the integration and management of multiple channels to help enterprises reach overseas users more efficiently. With this, Aurora Mobile helps Chinese enterprises who seek international expansion to build closer and more efficient connections with users, supporting their sustainable and efficient development in overseas markets. With the messaging cloud at its core, the Solution will act as an important part of the company's 2022 strategy to develop new growth drivers.

05:50 EDT DXC Technology awarded a multi-year contract with European Space Agency - DXC Technology has been awarded a multi-year contract to deliver network and security services to provide the European Space Agency's international workforce of scientists, engineers and IT specialists with scalable and secure network services enabling them to collaborate seamlessly from anywhere on their space activities. Through the agreement, DXC will contribute to ESA's work to develop Europe's space capability, helping enable missions that study the Universe, explore our Solar System and orbit Earth, obtaining crucial data that allow us to monitor and mitigate the effects of climate change. DXC will help transform ESA's terrestrial network environment with the latest software-defined network technology designed to improve network scalability, performance, and security. As a result, ESA's global workforce will collaborate more efficiently with colleagues and international partners on some of the world's leading science and exploration missions. In parallel, the implementation of DXC's Platform X, a new data-driven intelligent automation platform, will enable ESA to achieve a state of silent operations for its network and security systems.